J. V. D. van der Meer

B. Alisjahbana, T. Ottenhoff, J. V. D. van der Meer, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) IN MENINGOCOCCAL SEPTIC SHOCK AND EXPERIMENTAL HUMAN ENDOTOXEMIA

T. Calandra, A. Geurts-Moespot, D. Leroy, 2007, Shock.

Effect of Clarithromycin in Inflammatory Markers of Patients with Ventilator-Associated Pneumonia and Sepsis Caused by Gram-Negative Bacteria: Results from a Randomized Clinical Study

M. Netea, S. Orfanos, A. Kotanidou, 2012, Antimicrobial Agents and Chemotherapy.

Inhibition of caspase-1 activation in gram-negative sepsis and experimental endotoxemia

L. Joosten, M. Netea, J. V. D. van der Meer, 2011, Critical care.

Innate immune memory: towards a better understanding of host defense mechanisms.

M. Netea, Shih-Chin Cheng, J. V. D. van der Meer, 2014, Current opinion in immunology.

TREM-1 interaction with the LPS/TLR4 receptor complex.

L. Joosten, M. Netea, C. Dinarello, 2011, European cytokine network.

Scintigraphic detection of acute experimental endocarditis with the technetium-99m labelled glycoprotein IIb/IIIa receptor antagonist DMP444

W. Oyen, D. Ruiter, J. V. D. van der Meer, 2000, European Journal of Nuclear Medicine.

Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis.

W. Oyen, J. V. D. van der Meer, O. Boerman, 2003, Clinical nuclear medicine.

Anti-ribosomal P antibodies as a single serological marker in SLE: lupus in disguise

J. V. D. van der Meer, J. Berden, J. Kleinnijenhuis, 2013, Scandinavian journal of rheumatology.

Vascular endothelial growth factor in systemic capillary leak syndrome.

C. Punt, F. Sweep, W. Leenders, 2009, The American journal of medicine.

The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity.

L. Joosten, M. Netea, M. Wabitsch, 2010, Cell metabolism.

The Role of Dectin-2 for Host Defense Against Disseminated Candidiasis

L. Joosten, M. Netea, N. Gow, 2016, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Role of Dectin-2 for Host Defense against Systemic Infection with Candida glabrata

M. Oosting, L. Joosten, M. Netea, 2013, Infection and Immunity.

IL-18 serum concentration is markedly elevated in acute EBV infection and can serve as a marker for disease severity.

L. Joosten, M. Netea, J. V. D. van der Meer, 2012, The Journal of infectious diseases.

The dectin-1/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans

Duccio Cavalieri, Lisa Rizzetto, Leo A. B. Joosten, 2011, Journal of leukocyte biology.

Human dectin-1 deficiency and mucocutaneous fungal infections.

Trees Jansen, L. Jacobs, L. Joosten, 2009, The New England journal of medicine.

Candida albicans Releases Soluble Factors That Potentiate Cytokine Production by Human Cells through a Protease-Activated Receptor 1- and 2-Independent Pathway

L. Joosten, M. Netea, Shih-Chin Cheng, 2009, Infection and Immunity.

Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy

M. Netea, B. Kullberg, J. V. D. van der Meer, 2006, Expert opinion on biological therapy.

Host-microbe interactions: innate pattern recognition of fungal pathogens.

M. Netea, N. Gow, B. Kullberg, 2008, Current opinion in microbiology.

Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis

M. Netea, P. V. van Riel, J. Meer, 2004, Annals of the rheumatic diseases.

In vivo expression of interleukin-1 receptors during various experimentally induced inflammatory conditions.

W. Oyen, J. V. D. van der Meer, O. Boerman, 1998, The Journal of infectious diseases.

Y-Chromosome Analysis in Individuals Bearing the Basarab Name of the First Dynasty of Wallachian Kings

M. Netea, D. Comas, L. Kalaydjieva, 2012, PloS one.

Immune recognition of putative alien microbial structures: Host–pathogen interactions in the age of space travel

M. Netea, N. Gow, H. O. D. op den Camp, 2020, PLoS pathogens.

The short-term and long-term effectiveness of a multidisciplinary hand hygiene improvement program.

T. van Achterberg, M. Hulscher, J. V. D. van der Meer, 2012, American journal of infection control.

Is cognitive behaviour therapy for chronic fatigue syndrome also effective for pain symptoms?

G. Bleijenberg, H. Knoop, J. Prins, 2007, Behaviour research and therapy.

Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria.

J. V. D. van der Meer, A. Dofferhoff, J. Mouton, 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Reactive oxygen species–independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease

S. Smeekens, L. Joosten, M. Netea, 2010, Proceedings of the National Academy of Sciences.

Micronutrient deficiency and supplementation in Indonesian infants. Effects on immune function.

J. V. D. van der Meer, J. van der Ven-Jongekrijg, C. West, 2003, Advances in experimental medicine and biology.

Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections.

R. Sauerwein, J. V. D. van der Meer, M. Deuren, 1995, The Journal of infectious diseases.

Receptor Recognition of and Immune Intracellular Pathways for Veillonella parvula Lipopolysaccharide

L. Joosten, M. Netea, B. Kullberg, 2009, Clinical and Vaccine Immunology.

Natural course and predicting self-reported improvement in patients with chronic fatigue syndrome with a relatively short illness duration.

G. Bleijenberg, J. V. D. van der Meer, S. P. van der Werf, 2002, Journal of psychosomatic research.

Elective orthopedic surgery, a model for the study of cytokine activation and regulation.

J. V. D. van der Meer, M. van Deuren, J. van der Ven-Jongekrijg, 1998, Cytokine.

Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection.

M. Netea, K. V. van Dijk, J. Meer, 1999, Journal of lipid research.

MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease

C. Wijmenga, M. Netea, E. Cuppen, 2013, Annals of the rheumatic diseases.

Familial Mediterranean fever--a not so unusual cause of abdominal pain.

J. Drenth, J. V. D. van der Meer, A. Simon, 2005, Best practice & research. Clinical gastroenterology.

A founder effect in the hyperimmunoglobulinemia D and periodic fever syndrome.

E. Mariman, J. Drenth, J. V. D. van der Meer, 2003, The American journal of medicine.

Genetic analysis as a valuable key to diagnosis and treatment of periodic Fever.

P. Tighe, J. V. D. van der Meer, M. van Deuren, 2001, Archives of internal medicine.

Familial periodic fever and amyloidosis due to a new mutation in the TNFRSF1A gene.

C. Dodé, J. V. D. van der Meer, A. Simon, 2001, The American journal of medicine.

Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes.

T. Bousema, G. van Gemert, R. Sauerwein, 2005, The Netherlands journal of medicine.

Oxidized Low-Density Lipoprotein Induces Long-Term Proinflammatory Cytokine Production and Foam Cell Formation via Epigenetic Reprogramming of Monocytes

L. Joosten, M. Netea, J. V. D. van der Meer, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Optimising antimicrobial drug use in surgery: an intervention study in a Dutch university hospital.

I. Gyssens, A. Kampen, J. V. D. van der Meer, 1996, The Journal of antimicrobial chemotherapy.

Cytokine Patterns in Patients After Major Vascular Surgery, Hemorrhagic Shock, and Severe Blunt Trauma Relation with Subsequent Adult Respiratory Distress Syndrome and Multiple Organ Failure

R. Sauerwein, G. Nieuwenhuijzen, J. V. D. van der Meer, 1993, Annals of surgery.

Infection control in a skilled nursing facility: a 6-year survey.

J. V. D. van der Meer, H. Cools, 1988, The Journal of hospital infection.

Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.

C. Schalkwijk, J. V. D. van der Meer, M. van Deuren, 1995, Blood.

Primary haemochromatosis: a missed cause of chronic fatigue syndrome?

G. Bleijenberg, D. Swinkels, J. V. D. van der Meer, 2002, The Netherlands journal of medicine.

Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever.

R. Tompkins, J. Meer, C. Dinarello, 1990, The Journal of infectious diseases.

99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation.

W. Oyen, H. Bakker, J. V. D. van der Meer, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Psychogenic periodic fever.

J. V. D. van der Meer, R. Timmerman, J. Thompson, 1992, The Netherlands journal of medicine.

Investigating neural mechanisms of change of cognitive behavioural therapy for chronic fatigue syndrome: a randomized controlled trial

I. Toni, K. Roelofs, F. D. de Lange, 2015, BMC Psychiatry.

Evaluating neuropsychological impairment in chronic fatigue syndrome.

G. Bleijenberg, E. Bazelmans, J. V. D. van der Meer, 1998, Journal of clinical and experimental neuropsychology.

Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1 beta infusion: in vivo and in vitro studies.

C. Sweep, T. Benraad, J. V. D. van der Meer, 1992, Endocrinology.

High-Mobility Group Nucleosome-Binding Protein 1 as Endogenous Ligand Induces Innate Immune Tolerance in a TLR4-Sirtuin-1 Dependent Manner in Human Blood Peripheral Mononuclear Cells

L. Joosten, M. Netea, Shih-Chin Cheng, 2018, Front. Immunol..

Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.

R. Grol, M. Hulscher, B. Kullberg, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Optimizing the timing of antimicrobial prophylaxis in surgery: an intervention study.

J. Meer, I. Gyssens, J. V. D. van der Meer, 1996, The Journal of antimicrobial chemotherapy.

A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol.

W. Oyen, J. V. D. van der Meer, Ton Dofferhoff, 2007, Medicine.

The Impact of Nontuberculous Myobacteria on Management of Presumed Pulmonary Tuberculosis

D. van Soolingen, J. Meer, B. Kullberg, 2001, Infection.

A double-blind, placebo-controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status.

J. V. D. van der Meer, W. Schultink, W. Dolmans, 2002, The American journal of clinical nutrition.

Impact of a maximal exercise test on symptoms and activity in chronic fatigue syndrome.

G. Bleijenberg, H. Folgering, E. Bazelmans, 2005, Journal of psychosomatic research.

The effect of a polynutrient supplement on fatigue and physical activity of patients with chronic fatigue syndrome: a double-blind randomized controlled trial.

G. Bleijenberg, J. V. D. van der Meer, S. Werf, 2002, QJM : monthly journal of the Association of Physicians.

The chronic fatigue syndrome and hyperventilation.

G. Bleijenberg, H. Folgering, E. Bazelmans, 1997, Journal of psychosomatic research.

Prognosis in chronic fatigue syndrome: a prospective study on the natural course.

G. Bleijenberg, J. Meer, J. V. D. van der Meer, 1996, Journal of neurology, neurosurgery, and psychiatry.

Reply to: Chronic fatigue syndrome: a clinical and laboratory study with a well‐matched control group

G. Bleijenberg, J. V. D. van der Meer, J. Vercoulen, 2004, Journal of internal medicine.

Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy.

M. Netea, P. V. van Riel, T. Radstake, 2005, Cytokine.

Innate immunity to Mycobacterium tuberculosis.

T. Ottenhoff, J. V. D. van der Meer, R. van Crevel, 2003, Advances in experimental medicine and biology.

Imaging of infection in rabbits with radioiodinated interleukin-1 (α and β), its receptor antagonist and a chemotactic peptide: a comparative study

W. Oyen, J. V. D. van der Meer, O. Boerman, 1998, European Journal of Nuclear Medicine.

[Optimization of the antibiotics policy in the Netherlands. II. SWAB guidelines for the antimicrobial therapy of pneumonia in patients at home and as nosocomial infections. The Netherlands Antibiotic Policy Foundation].

W. Wijnands, J. V. D. van der Meer, M. V. van Kasteren, 1998, Nederlands tijdschrift voor geneeskunde.

Decontamination of Oral or Digestive Tract for Patients in the Intensive Care Unit.

J. V. D. van der Meer, C. Vandenbroucke-Grauls, 2018, JAMA.

Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy.

A. Girbes, P. Speelman, M. Bonten, 2000, The Journal of antimicrobial chemotherapy.

LPS-induced cytokine production and expression of LPS-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors.

M. Netea, J. V. D. van der Meer, P. Demacker, 1998, Atherosclerosis.

Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome

J. Schalkwijk, J. V. D. van der Meer, J. van der Ven-Jongekrijg, 2012, Annals of the rheumatic diseases.

The anaesthetist as determinant factor of quality of surgical antimicrobial prophylaxis. A survey in a university hospital.

I. Gyssens, J. V. D. van der Meer, G. V. Van Hal, 1997, Pharmacy World and Science.

Restriction of long-term indwelling urethral catheterisation in the elderly.

J. V. D. van der Meer, H. Cools, H. Cools, 1986, British journal of urology.

Benign uterine uptake of FDG: a case report and review of literature.

D. Vriens, W. Oyen, L. de Geus-Oei, 2010, The Netherlands journal of medicine.

Redistribution of vitamin A after iron supplementation in Indonesian infants.

J. V. D. van der Meer, C. West, F. Wieringa, 2003, The American journal of clinical nutrition.

F‐18‐fluorodeoxyglucose positron emission tomography leading to a diagnosis of septic thrombophlebitis of the portal vein: description of a case history and review of the literature

W. Oyen, C. Tack, J. V. D. van der Meer, 2004, Journal of internal medicine.

Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis.

W. Oyen, J. V. D. van der Meer, S. Bredie, 2004, The American journal of medicine.

F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis.

W. Oyen, J. V. D. van der Meer, S. Bredie, 2003, The Netherlands journal of medicine.

Better patient instruction for sputum sampling can improve microscopic tuberculosis diagnosis.

B. Alisjahbana, J. V. D. van der Meer, R. van Crevel, 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients.

A. van der Lelij, J. V. D. van der Meer, L. Los, 2007, Ophthalmology.

Effects of antirheumatic agents on cytokines.

J. V. D. van der Meer, L. van de Putte, P. Barrera, 1996, Seminars in arthritis and rheumatism.

Pneumococcal aortitis, report of a case with emphasis on the contribution to diagnosis of positron emission tomography using fluorinated deoxyglucose.

W. Oyen, J. V. D. van der Meer, A. V. van Dijk, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Transpleural lung biopsy by the thoracoscopic route in patients with diffuse interstitial pulmonary disease.

J. V. D. van der Meer, J. Dijkman, P. J. van der Broek, 1982, Chest.

Engagement of NOD2 has a dual effect on proIL‐1β mRNA transcription and secretion of bioactive IL‐1β

L. Joosten, M. Netea, S. Girardin, 2008, European journal of immunology.

Candida albicans Dampens Host Defense by Downregulating IL-17 Production

S. Smeekens, L. Joosten, M. Netea, 2010, The Journal of Immunology.

Role of autophagy genetic variants for the risk of Candida infections.

M. Oosting, L. Joosten, M. Netea, 2014, Medical mycology.

Association of toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms with increased infection risk in patients with advanced HIV-1 infection.

M. Netea, V. Sakka, B. Ferwerda, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association of esophageal candidiasis and squamous cell carcinoma.

B. Kullberg, J. V. D. van der Meer, J. Tol, 2012, Medical mycology case reports.

Factors influencing the incidence of infections in Felty's syndrome.

A. Cats, F. Breedveld, J. Hermans, 1987, Archives of internal medicine.

Central delivery of iodine-125–labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating Alzheimer’s disease

J. V. D. van der Meer, O. Boerman, R. Groen, 2015, Alzheimer's Research & Therapy.

Specific and rapid scintigraphic detection of infection with 99mTc-labeled interleukin-8.

W. Oyen, J. V. D. van der Meer, O. Boerman, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia

J. V. D. van der Meer, M. van Deuren, T. Sprong, 2009, Clinical and experimental immunology.

Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency.

J. Raemaekers, J. V. D. van der Meer, J. Jansen, 2006, The Netherlands journal of medicine.

Improving the process of antibiotic therapy in daily practice: interventions to optimize timing, dosage adjustment to renal function, and switch therapy.

B. Kullberg, J. V. D. van der Meer, M. V. van Kasteren, 2004, Archives of internal medicine.

Use of fluconazole in daily practice: still room for improvement.

J. Meis, B. Kullberg, J. V. D. van der Meer, 2001, The Journal of antimicrobial chemotherapy.

Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment.

D. van Soolingen, J. Meer, J. V. D. van der Meer, 2001, Emerging infectious diseases.

Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia.

B. Alisjahbana, T. Ottenhoff, D. van Soolingen, 2010, The Journal of infectious diseases.

Infection with Mycobacterium tuberculosis Beijing genotype strains is associated with polymorphisms in SLC11A1/NRAMP1 in Indonesian patients with tuberculosis.

M. Netea, B. Alisjahbana, T. Ottenhoff, 2009, The Journal of infectious diseases.

Molecular Analysis of the Mevalonate Kinase Gene in a Cohort of Patients with the Hyper-IgD and Periodic Fever Syndrome: Its Application as a Diagnostic Tool

L. Cuisset, J. Drenth, J. V. D. van der Meer, 2001, Annals of Internal Medicine.

Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2004, Microbes and infection.

Validity, reliability and feasibility of a new observation rating tool and a post encounter rating tool for the assessment of clinical reasoning skills of medical students during their internal medicine clerkship: a pilot study

J. V. D. van der Meer, C. M. Haring, B. Cools, 2020, BMC medical education.

Why don't medical textbooks teach? The lack of logic in the differential diagnosis.

J. V. D. van der Meer, P. F. De Vries Robbé, P. Stuyt, 2003, The Netherlands journal of medicine.

Circulating Leptin and Adiponectin Concentrations During Tumor Necrosis Factor Blockade in Patients with Active Rheumatoid Arthritis

M. Netea, P. V. van Riel, F. V. D. van den Hoogen, 2009, The Journal of Rheumatology.

Cefsulodin for the treatment of Pseudomonas infections--a study comparing cefsulodin and ticarcillin.

J. V. D. van der Meer, H. Mattie, A. Matze-van der Lans, 1989, The Netherlands journal of medicine.

Induction of tumor necrosis factor during extracorporeal blood purification.

C. Dinarello, J. V. D. van der Meer, J. Cannon, 1987, The New England journal of medicine.

Alpha+ -thalassemia protects against anemia associated with asymptomatic malaria: evidence from community-based surveys in Tanzania and Kenya.

R. Olomi, J. V. D. van der Meer, R. Kraaijenhagen, 2008, The Journal of infectious diseases.

Low dosages of interleukin 1 protect mice against lethal cerebral malaria

R. Sauerwein, W. Eling, J. V. D. van der Meer, 1990, The Journal of experimental medicine.

Chronic intraperitoneal infusion of low doses of tumor necrosis factor alpha in rats induces a reduction in plasma triglyceride levels.

C. Sweep, T. Benraad, J. V. D. van der Meer, 1992, Cytokine.

Continuous infusion of interleukin-1 beta in rats induces a profound fall in plasma levels of cholesterol and triglycerides.

C. Sweep, J. V. D. van der Meer, P. Demacker, 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

Inflammatory cytokines in an experimental model for the multiple organ dysfunction syndrome.

R. Goris, J. V. D. van der Meer, T. Hendriks, 1996, Critical care medicine.

Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer

L. Kiemeney, R. Xavier, M. Oosting, 2014, PLoS pathogens.

Long-Lasting Effects of BCG Vaccination on Both Heterologous Th1/Th17 Responses and Innate Trained Immunity

R. Xavier, L. Joosten, M. Netea, 2013, Journal of Innate Immunity.

The effect of salicylates on insulin sensitivity.

M. Netea, C. Tack, J. V. D. van der Meer, 2001, The Journal of clinical investigation.

Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.

R. Sauerwein, J. V. D. van der Meer, L. van de Putte, 1993, Arthritis and rheumatism.

Blocking IL-1β to slow down progression of ALS?

J. V. D. van der Meer, A. Simon, A. Simon, 2010, Proceedings of the National Academy of Sciences.

Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages.

L. Joosten, M. Netea, C. Dinarello, 2009, Blood.

Interleukin-1 beta in human plasma: optimization of blood collection, plasma extraction, and radioimmunoassay methods.

J. Meer, C. Dinarello, J. V. D. van der Meer, 1988, Lymphokine research.

Diabetes mellitus is strongly associated with tuberculosis in Indonesia.

B. Alisjahbana, M. den Heijer, T. Ottenhoff, 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Increased interleukin-1alpha and interleukin-1beta production by macrophages of low-density lipoprotein receptor knock-out mice stimulated with lipopolysaccharide is CD11c/CD18-receptor mediated.

M. Netea, B. Kullberg, J. V. D. van der Meer, 1998, Immunology.

The Role of Cytokines in Activation of Coagulation and Fibrinolysis in Dengue Shock Syndrome

J. V. D. van der Meer, C. Hack, H. ten Cate, 2002, Thrombosis and Haemostasis.

Side effects of anticytokine strategies.

M. Netea, J. V. D. van der Meer, C. Popa, 2005, The Netherlands journal of medicine.

Diagnosing infection in febrile granulocytopenic patients with indium-111-labeled human immunoglobulin G.

W. Oyen, J. Raemaekers, J. V. D. van der Meer, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Indium-111-labeled human nonspecific immunoglobulin G: a new radiopharmaceutical for imaging infectious and inflammatory foci.

W. Oyen, R. Rubin, H. Strauss, 1992, Clinical Infectious Diseases.

Detection of subacute infectious foci with indium-111-labeled autologous leukocytes and indium-111-labeled human nonspecific immunoglobulin G: a prospective comparative study.

W. Oyen, J. V. D. van der Meer, F. Corstens, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Chemotactic peptides: new locomotion for imaging of infection?

J. V. D. van der Meer, F. Corstens, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Defining trained immunity and its role in health and disease

R. Xavier, L. Joosten, M. Netea, 2020, Nature Reviews Immunology.

Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever.

J. V. D. van der Meer, P. Demacker, W. Dolmans, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats.

W. Oyen, J. V. D. van der Meer, O. Boerman, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Technetium-99m-labeled liposomes to image experimental colitis in rabbits: comparison with technetium-99m-HMPAO-granulocytes and technetium-99m-HYNIC-IgG.

W. Oyen, J. V. D. van der Meer, O. Boerman, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Sterically stabilized liposomes labeled with indium-111 to image focal infection.

W. Oyen, D. Crommelin, J. Meer, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Scintigraphic evaluation of experimental chronic osteomyelitis.

W. Oyen, J. V. D. van der Meer, O. Boerman, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Imaging experimental intraabdominal abscesses with 99mTc-PEG liposomes and 99mTc-HYNIC IgG.

W. Oyen, G. Storm, H. van Goor, 1999, Annals of surgery.

Rapid imaging of experimental infection with technetium-99m-DTPA after anti-DTPA monoclonal antibody priming.

W. Oyen, E. Oosterwijk, J. V. D. van der Meer, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Biodistribution of 111In‐labelled IgG and IgM in experimental infection

W. Oyen, J. V. D. van der Meer, O. Boerman, 1996, Nuclear medicine communications.

Biodistribution and kinetics of radiolabeled proteins in rats with focal infection.

W. Oyen, J. V. D. van der Meer, F. Corstens, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction.

M. Oosting, L. Joosten, M. Netea, 2010, The Journal of infectious diseases.

Nucleotide Oligomerization Domain 2 (Nod2) Is Not Involved in the Pattern Recognition of Candida albicans

B. Franke, M. Netea, S. Girardin, 2006, Clinical and Vaccine Immunology.

Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release 1

L. Jacobs, M. Netea, S. Girardin, 2005, The Journal of Immunology.

Circulating interleukin-6 receptor in patients with sepsis syndrome.

R. Sauerwein, J. V. D. van der Meer, M. Deuren, 1995, The Journal of infectious diseases.

Treating inflammation by blocking interleukin-1 in humans.

C. Dinarello, J. V. D. van der Meer, 2013, Seminars in immunology.

Circulating cytokines as mediators of fever.

M. Netea, J. Meer, B. Kullberg, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The dense low-density lipoprotein (LDL) subfractions are more potent than buoyant LDL for binding and neutralization of lipopolysaccharide

L. Jacobs, M. Netea, J. V. D. van der Meer, 1997 .

PENTRAXIN 3 AND C-REACTIVE PROTEIN IN SEVERE MENINGOCOCCAL DISEASE

A. Mantovani, J. V. D. van der Meer, M. van Deuren, 2009, Shock.

Trained immunity: A smart way to enhance innate immune defence.

L. Joosten, M. Netea, J. V. D. van der Meer, 2015, Molecular immunology.

Differential Cytokine Production and Toll-Like Receptor Signaling Pathways by Candida albicans Blastoconidia and Hyphae

M. Netea, B. Kullberg, J. V. D. van der Meer, 2005, Infection and Immunity.

Ebola Virus Disease has Features of Hemophagocytic Lymphohistiocytosis Syndrome

M. Netea, J. V. D. van der Meer, Q. de Mast, 2015, Front. Med..

NFKB1 regulates human NK cell maturation and effector functions.

V. Lougaris, A. Plebani, G. Tabellini, 2017, Clinical immunology.

Scintigraphic detection of bone and joint infections with indium-111-labeled nonspecific polyclonal human immunoglobulin G.

W. Oyen, J. V. van Horn, J. V. D. van der Meer, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: first clinical evaluation.

W. Oyen, E. Visser, J. V. D. van der Meer, 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: a clinical study.

W. Oyen, J. V. D. van der Meer, O. Boerman, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Immune recognition of Candida albicans beta-glucan by dectin-1.

Trees Jansen, L. Jacobs, M. Netea, 2007, The Journal of infectious diseases.

Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: two diseases with distinct clinical, serologic, and genetic features.

M. Pras, E. Pras, J. V. D. van der Meer, 1997, The Journal of rheumatology.

Human TLR10 is an anti-inflammatory pattern-recognition receptor

A. Hoischen, M. Oosting, L. Joosten, 2014, Proceedings of the National Academy of Sciences.

Increased voluntary exercise in mice deficient for tumour necrosis factor‐α and lymphotoxin‐α

M. Netea, B. Kullberg, J. V. D. van der Meer, 2007, European journal of clinical investigation.

Variation in Genes of β-glucan Recognition Pathway and Susceptibility to Opportunistic Infections in HIV-Positive Patients

L. Joosten, M. Netea, H. Venselaar, 2011, Immunological investigations.

Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment.

J. V. D. van der Meer, H. D. de Koning, A. Simon, 2007, Seminars in arthritis and rheumatism.

Antibiotic use in Dutch hospitals 1991-1996.

J. V. D. van der Meer, I. Gould, A. O. Oude Lashof, 2000, The Journal of antimicrobial chemotherapy.

Delayed clearance of intraabdominal abscesses caused by Candida albicans in tumor necrosis factor-alpha- and lymphotoxin-alpha-deficient mice.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2002, The Journal of infectious diseases.

Persistence of full-length caspase-12 and its relation to malaria in West and Central African populations.

M. Netea, O. Doumbo, R. Sauerwein, 2010, European cytokine network.

The Effect of Two Different Dosages of Intravenous Immunoglobulin on the Incidence of Recurrent Infections in Patients with Primary Hypogammaglobulinemia

C. Kallenberg, J. V. D. van der Meer, P. Strengers, 2001, Annals of Internal Medicine.

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial.

C. Kallenberg, J. V. D. van der Meer, J. V. van Dissel, 2001, Annals of internal medicine.

Hyperimmunoglobulinemia D and Periodic Fever Syndrome: The Clinical Spectrum in a Series of 50 Patients

J. V. D. van der Meer, C. Haagsma, J. Drenth, 1994, Medicine.

Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper IgD Study Group.

J. V. D. van der Meer, J. Drenth, B. W. Boom, 1994, Archives of dermatology.

Borrelia species induce inflammasome activation and IL‐17 production through a caspase‐1‐dependent mechanism

M. Oosting, L. Joosten, M. Netea, 2011, European journal of immunology.

Removal of interleukin-1 beta and tumor necrosis factor from human plasma by in vitro dialysis with polyacrylonitrile membranes.

J. Wetzels, J. V. D. van der Meer, P. Demacker, 1992, Lymphokine and cytokine research.

The role of interleukin-1 beta in the pathophysiology of Schnitzler’s syndrome

J. Schalkwijk, H. Koenen, I. Joosten, 2015, Arthritis Research & Therapy.

CSF concentrations of ketoconazole.

J. V. D. van der Meer, W. Fibbe, R. Mouton, 1980, The Journal of antimicrobial chemotherapy.

The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice.

M. Netea, J. Meer, B. Kullberg, 1997, Blood.

Chronic Fatigue Syndrome and Primary Fibromyalgia Syndrome as recognized by GPs.

C. van Weel, G. Bleijenberg, E. Bazelmans, 1999, Family practice.

Murine Borrelia arthritis is highly dependent on ASC and caspase-1, but independent of NLRP3

M. Oosting, L. Joosten, M. Netea, 2012, Arthritis Research & Therapy.

Myeloid lineage-restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome.

P. Jansen, I. Nijman, M. van Gijn, 2015, The Journal of allergy and clinical immunology.

Quality of antimicrobial drug prescription in hospital.

I. Gyssens, J. V. D. van der Meer, 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1β by mononuclear cells through a caspase 1-mediated process

M. Netea, B. Kullberg, J. V. D. van der Meer, 2008, Annals of the rheumatic diseases.

The inflammasome--a linebacker of innate defense.

J. Drenth, J. V. D. van der Meer, 2006, The New England journal of medicine.

Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome.

J. Drenth, J. V. D. van der Meer, W. V. van Heerde, 2007, Blood.

Protodyne: an immunostimulatory protein component, prepared from gram-positive Bacillus subtilis.

J. Vilček, C. Dinarello, J. V. D. van der Meer, 1992, Developments in biological standardization.

Enhanced interleukin-1β production of PBMCs from patients with gout after stimulation with Toll-like receptor-2 ligands and urate crystals

L. Joosten, M. Netea, E. Mylona, 2012, Arthritis Research & Therapy.

A space-occupying lesion of the skull base, masked by nasopharyngeal lymphatic tissue hypertrophy and causing cranial nerve dysfunction in an HIV-infected patient

C. Majoie, J. V. D. van der Meer, H. van der Vliet, 2002, Annals of Hematology.

Author Correction: Trained immunity, tolerance, priming and differentiation: distinct immunological processes

R. Xavier, L. Joosten, M. Netea, 2021, Nature immunology.

Caspase-12 and the Inflammatory Response to Yersinia pestis

L. Joosten, M. Netea, O. Doumbo, 2009, PLoS ONE.

Chlamydia pneumoniae stimulates IFN-gamma synthesis through MyD88-dependent, TLR2- and TLR4-independent induction of IL-18 release.

L. Jacobs, M. Netea, J. Galama, 2004, Journal of immunology.

A man with a mysterious hypogammaglobulinaemia and skin rash.

J. V. D. van der Meer, P. Netten, E. V. van Ginneken, 1999, The Netherlands journal of medicine.

Effects of interleukin-8 on nonspecific resistance to infection in neutropenic and normal mice

W. Eling, J. V. D. van der Meer, J. Curfs, 1993, Antimicrobial Agents and Chemotherapy.

The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B.

J. V. D. van der Meer, W. Fibbe, C. Verhagen, 1991, The Journal of infection.

The challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndrome.

J. V. D. van der Meer, A. Simon, 2016, Rheumatology.

The Janus face of Bartonella quintana recognition by Toll-like receptors (TLRs): a review.

L. Joosten, M. Netea, B. Kullberg, 2008, European cytokine network.

Dosing of amoxicillin/clavulanate for treatment of lower respiratory tract infection.

J. V. D. van der Meer, S. Natsch, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cytokine Production Assays Reveal Discriminatory Immune Defects in Adults with Recurrent Infections and Noninfectious Inflammation

L. Joosten, M. Netea, I. Gyssens, 2014, Clinical and Vaccine Immunology.

Beneficial response to interleukin 1 receptor antagonist in traps.

J. Drenth, J. V. D. van der Meer, J. V. D. van der Hilst, 2004, The American journal of medicine.

Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism.

L. Jacobs, L. Joosten, M. Netea, 2005, Cytokine.

Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor.

J. Meer, C. Dinarello, J. V. D. van der Meer, 1988, Clinical immunology and immunopathology.

Redundant role of TLR9 for anti-Candida host defense.

Trees Jansen, L. Jacobs, M. Netea, 2008, Immunobiology.

Cytokine production from stimulated whole blood cultures in rheumatoid arthritis patients treated with various TNF blocking agents.

L. Joosten, M. Netea, P. V. van Riel, 2009, European cytokine network.

Regulation of Staphylococcus epidermidis-induced IFN-gamma in whole human blood: the role of endogenous IL-18, IL-12, IL-1, and TNF.

M. Netea, G. Fantuzzi, C. Dinarello, 2003, Cytokine.

Apolipoprotein-E-deficient mice exhibit an increased susceptibility to disseminated candidiasis.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2004, Medical mycology.

Role of Interleukin-18 in Host Defense against Disseminated Candida albicans Infection

M. Netea, G. Fantuzzi, C. Dinarello, 2002, Infection and Immunity.

ATP-Induced IL-1β Specific Secretion: True Under Stringent Conditions

C. Dinarello, J. V. D. van der Meer, A. Simon, 2015, Front. Immunol..

LPS-induced cytokine production and expression of beta2-integrins and CD14 by peripheral blood mononuclear cells of patients with homozygous familial hypercholesterolemia.

M. Netea, B. Kullberg, J. V. D. van der Meer, 1998, Atherosclerosis.

Th17 responses and host defense against microorganisms: an overview.

L. Joosten, M. Netea, M. Gresnigt, 2009, BMB reports.

Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation.

W. Oyen, J. V. D. van der Meer, O. Boerman, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management

J. V. D. van der Meer, M. van Deuren, P. Brandtzaeg, 2000, Clinical Microbiology Reviews.

Aspergillus fumigatus cell wall components differentially modulate host TLR2 and TLR4 responses.

L. Joosten, M. Netea, J. Latgé, 2011, Microbes and infection.

[Optimizing antibiotics use policy in the Netherlands. I. The Netherlands Antibiotics Policy Foundation (SWAB)].

W. Wijnands, J. V. D. van der Meer, M. V. van Kasteren, 1998, Nederlands tijdschrift voor geneeskunde.

Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial.

M. Netea, C. Dinarello, A. Katoulis, 2016, JAMA dermatology.

Acyclovir for herpes zoster.

J. V. D. van der Meer, P. J. van den Broek, P. Stuyt, 1994, The New England journal of medicine.

Altered antigen-presentation in the induction of the in-vitro antigen-specific T helper cell function in patients with chronic granulomatous disease.

J. V. D. van der Meer, C. Heijnen, B. Zegers, 1986, Clinical and experimental immunology.

Candida albicans Primes TLR Cytokine Responses through a Dectin-1/Raf-1–Mediated Pathway

Trees Jansen, L. Jacobs, L. Joosten, 2013, Journal of Immunology.

Neutrophil-Mediated Inhibition of Proinflammatory Cytokine Responses

L. Joosten, M. Netea, C. Dinarello, 2012, The Journal of Immunology.

Variable recognition of Candida albicans strains by TLR4 and lectin recognition receptors.

L. Joosten, M. Netea, N. Gow, 2010, Medical mycology.

Overt thyroid dysfunction and anti-thyroid antibodies predict response to anti-PD-1 immunotherapy in cancer patients.

J. Aerts, R. Peeters, R. Mathijssen, 2020, Thyroid : official journal of the American Thyroid Association.

The classical CD14++CD16− monocytes, but not the patrolling CD14+CD16+ monocytes, promote Th17 responses to Candida albicans

S. Smeekens, Trees Jansen, L. Jacobs, 2011, European journal of immunology.

Influence of innate cytokine production capacity on clinical manifestation and severity of pediatric meningococcal disease

J. V. D. van der Meer, M. van Deuren, T. Sprong, 2009, Critical care medicine.

Mannose binding lectin enhances IL-1beta and IL-10 induction by non-lipopolysaccharide (LPS) components of Neisseria meningitidis.

L. Jacobs, D. Jack, N. Klein, 2004, Cytokine.

The Pattern of Interleukin-1/8 (IL-1/3) and Its Modulating Agents IL-1 Receptor Antagonist and IL-1 Soluble Receptor Type II in Acute Meningococcal Infections

C. Dinarello, J. V. D. van der Meer, M. van Deuren, 2017 .

Plasma patterns of tumor necrosis factor-alpha (TNF) and TNF soluble receptors during acute meningococcal infections and the effect of plasma exchange.

J. V. D. van der Meer, M. Deuren, M. van Deuren, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Possible Detrimental Effects of Cognitive Behaviour Therapy for Chronic Fatigue Syndrome

G. Bleijenberg, M. Heins, H. Knoop, 2010, Psychotherapy and Psychosomatics.

The effect of cognitive behaviour therapy for chronic fatigue syndrome on self-reported cognitive impairments and neuropsychological test performance

G. Bleijenberg, H. Knoop, J. Prins, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

Abnormal neuropsychological findings are not necessarily a sign of cerebral impairment: a matched comparison between chronic fatigue syndrome and multiple sclerosis.

G. Bleijenberg, P. Jongen, J. Prins, 2000, Neuropsychiatry, neuropsychology, and behavioral neurology.

Assessing and regulating homeopathic products

D. Larhammar, V. ter meulen, J. V. D. van der Meer, 2017, Journal of internal medicine.

Interleukin 10 mitigates the development of the zymosan-induced multiple organ dysfunction syndrome in mice.

J. V. D. van der Meer, T. Hendriks, R. Goris, 1999, Cytokine.

Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia

K. van der Velden, J. V. D. van der Meer, W. Dolmans, 2010, Nutrition journal.

Soluble murine IL-1 receptor type I induces release of constitutive IL-1 alpha.

M. Netea, C. Dinarello, B. Kullberg, 1999, Journal of immunology.

Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections.

M. Netea, J. Meer, B. Kullberg, 1996, The Journal of clinical investigation.

Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37

M. Oosting, L. Joosten, M. Netea, 2015, Front. Microbiol..

Differential susceptibility to lethal endotoxaemia in mice deficient in IL‐1α, IL‐1β or IL‐1 receptor type I

L. Joosten, M. Netea, T. van der Poll, 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.

J. V. D. van der Meer, A. Dofferhoff, J. Mouton, 2007, The Journal of antimicrobial chemotherapy.

Recombinant interleukin-18 protects against disseminated Candida albicans infection in mice.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2004, The Journal of infectious diseases.

Treatment of Intra-Abdominal Abscesses Caused by Candida albicans with Antifungal Agents and Recombinant Murine Granulocyte Colony-Stimulating Factor

M. Netea, B. Kullberg, J. V. D. van der Meer, 2003, Antimicrobial Agents and Chemotherapy.

Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice.

M. Netea, C. Sweep, J. Meis, 1999, Medical mycology.

Fas-FasL interactions modulate host defense against systemic Candida albicans infection.

M. Netea, J. Meis, B. Kullberg, 1999, The Journal of infectious diseases.

Infusion of lipoproteins into volunteers enhances the growth of Candida albicans.

M. Netea, J. Meis, B. Kullberg, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in nonneutropenic mice.

M. Netea, J. Meis, B. Kullberg, 1998, The Journal of infectious diseases.

A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection.

J. Meer, C. Dinarello, J. V. D. van der Meer, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of the clinical and immunological phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations.

William J. Astle, Sri V. V. Deevi, Kenneth G. C. Smith, 2020, The Journal of allergy and clinical immunology.

Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice.

M. Netea, B. Kullberg, J. V. D. van der Meer, 1999, FEMS immunology and medical microbiology.

Deficient Candida-specific T-helper 17 response during sepsis.

M. Netea, J. V. D. van der Meer, P. Pickkers, 2012, The Journal of infectious diseases.

Adaptation and memory in innate immunity.

L. Joosten, M. Netea, J. V. D. van der Meer, 2016, Seminars in immunology.

IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist

L. Joosten, M. Netea, C. Dinarello, 2012, Proceedings of the National Academy of Sciences.

Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise.

W. Oyen, J. V. D. van der Meer, C. Bleeker‐Rovers, 2018, Clinical radiology.

Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice.

M. Netea, C. Sweep, J. Meis, 2008, Medical mycology.

Oxidation of low-density lipoproteins by acellular components of Chlamydia pneumoniae.

L. Jacobs, M. Netea, C. Dinarello, 2000, The Journal of infectious diseases.

Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome

M. Netea, J. V. D. van der Meer, M. van Deuren, 2020, eLife.

Normal responses to specific NOD1 ligands.

M. Netea, S. Girardin, J. V. D. van der Meer, 2006, European journal of immunology.

Compartmentalized Cytokine Responses in Hidradenitis Suppurativa

M. Netea, J. V. D. van der Meer, E. Giamarellos‐Bourboulis, 2015, PloS one.

Evaluation of infections of the locomotor system with indium-111-labeled human IgG scintigraphy.

W. Oyen, J. V. D. van der Meer, M. Nijhof, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Sepsis--theory and therapies.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2003, The New England journal of medicine.

Monochlorobimane does not selectively label glutathione in peripheral blood mononuclear cells.

J. V. D. van der Meer, A. J. van der Ven, H. Dolstra, 1994, Analytical biochemistry.

Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis.

P. van Riel, G. Borm, J. V. D. van der Meer, 1995, British journal of rheumatology.

Role of acute-phase proteins in interleukin-1-induced nonspecific resistance to bacterial infections in mice

P. Ghezzi, J. V. D. van der Meer, M. Sironi, 1993, Antimicrobial Agents and Chemotherapy.

Mannose-binding lectin is a critical factor in systemic complement activation during meningococcal septic shock.

M. Netea, D. Swinkels, J. V. D. van der Meer, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.

J. V. D. van der Meer, M. van Deuren, P. Brandtzaeg, 2003, Blood.

Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells.

J. V. D. van der Meer, I. Kushner, J. Drenth, 1996, Journal of immunology.

Disease-specific ex vivo stimulation of whole blood for cytokine production: applications in the study of tuberculosis.

M. Netea, B. Kullberg, J. V. D. van der Meer, 1999, Journal of immunological methods.

Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts

M. Netea, D. Schwartz, P. Schlag, 2010, Critical care.

Bacterial lipopolysaccharide binds and stimulates cytokine-producing cells before neutralization by endogenous lipoproteins can occur.

L. Jacobs, M. Netea, B. Kullberg, 1998, Cytokine.

Immunoglobulin D enhances the release of tumour necrosis factor‐α, and interleukin‐1β as well as interleukin‐1 receptor antagonist from human mononuclear cells

M. Daha, J. V. D. van der Meer, J. van der Meer, 1996, Immunology.

Chlorpromazine down-regulates tumor necrosis factor-alpha and attenuates experimental multiple organ dysfunction syndrome in mice.

J. V. D. van der Meer, M. Knapen, T. Hendriks, 1998, Critical care medicine.

Complement Activation and Complement-Dependent Inflammation by Neisseria meningitidis Are Independent of Lipopolysaccharide

J. V. D. van der Meer, M. van Deuren, P. Brandtzaeg, 2004, Infection and Immunity.

A semi-quantitative reverse transcriptase polymerase chain reaction method for measurement of MRNA for TNF-alpha and IL-1 beta in whole blood cultures: its application in typhoid fever and exentric exercise.

M. Netea, E. Dharmana, J. V. D. van der Meer, 1996, Cytokine.

Interleukin-18 does not modulate the acute-phase response

M. Netea, C. Dinarello, B. Kullberg, 2005, Journal of endotoxin research.

Trained immunity, tolerance, priming and differentiation: distinct immunological processes

R. Xavier, L. Joosten, M. Netea, 2020, Nature Immunology.

18F-FDG PET in detecting metastatic infectious disease.

W. Oyen, B. Kullberg, J. V. D. van der Meer, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Update on meningococcal disease with emphasis on pathogenesis and clinical management.

J. V. D. van der Meer, M. Deuren, M. van Deuren, 2000, Clinical microbiology reviews.

Rhabdomyolysis during the subacute stage of meningococcal sepsis.

J. Wetzels, J. V. D. van der Meer, M. van Deuren, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fever of unknown origin.

W. Oyen, J. V. D. van der Meer, C. Bleeker‐Rovers, 2009, Seminars in nuclear medicine.

Recognition of fungal pathogens by toll-like receptors.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2006, Current pharmaceutical design.

Radiolabeled interleukin-8: specific scintigraphic detection of infection within a few hours.

W. Oyen, J. V. D. van der Meer, O. Boerman, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Interleukin-6 and human immunodeficiency virus load, but not plasma leptin concentration, predict anorexia and wasting in adults with pulmonary tuberculosis in Malawi.

J. V. D. van der Meer, R. Semba, C. West, 2005, The Journal of clinical endocrinology and metabolism.

Pneumococcal endocarditis in adult patients. A report of five cases and review of the literature.

J. V. D. van der Meer, G. Bruyn, J. Thompson, 1990, The Quarterly journal of medicine.

Enteroviruses and the chronic fatigue syndrome.

G. Bleijenberg, W. Melchers, J. V. D. van der Meer, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Interference of circulating azathioprine but not methotrexate or sulfasalazine with measurements of interleukin-6 bioactivity.

R. Sauerwein, J. V. D. van der Meer, L. van de Putte, 1994, Lymphokine and cytokine research.

An unusual case of severe combined immunodeficiency with hypereosinophilia

J. V. D. van der Meer, E. Dams, L. Schandené, 1997, Journal of internal medicine.

Acute respiratory insufficiency from psittacosis.

J. V. D. van der Meer, J. Versteeg, M. van Berkel, 1985, British medical journal.

Bacterial translocation in an experimental model of multiple organ dysfunctions.

M. Netea, J. V. D. van der Meer, J. van der Meer, 2013, The Journal of surgical research.

Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon- gamma therapy.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Emerging pathogens].

J. V. D. van der Meer, A. Overbeke, P. Kager, 1996, Nederlands tijdschrift voor geneeskunde.

Interleukin-1 (IL-1)-induced resistance to bacterial infection: role of the type I IL-1 receptor

W. Eling, J. V. D. van der Meer, M. Vogels, 1995, Antimicrobial agents and chemotherapy.

A possible link between recurrent upper respiratory tract infections and lower cytokine production in patients with Q fever fatigue syndrome

L. Joosten, M. Netea, J. V. D. van der Meer, 2019, European journal of immunology.

Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis

M. Netea, P. van Riel, J. Meer, 2005, Annals of the rheumatic diseases.

Multi-omics examination of Q fever fatigue syndrome identifies similarities with chronic fatigue syndrome

L. Joosten, M. Netea, Yang Li, 2020, Journal of translational medicine.

Early and late B-cell developmental impairment in nuclear factor kappa B, subunit 1-mutated common variable immunodeficiency disease.

V. Lougaris, A. Plebani, R. Badolato, 2017, The Journal of allergy and clinical immunology.

Th1/Th2 cytokine imbalance in a family with hyper-IgE syndrome.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2002, The Netherlands journal of medicine.

Autoimmunity and B-cell dyscrasia in acute and chronic Q fever: A review of the literature.

J. V. D. van der Meer, M. van Deuren, R. G. van der Molen, 2018, European journal of internal medicine.

Common variable immunodeficiency (CVID) in a family: an autosomal dominant mode of inheritance.

J. V. D. van der Meer, I. Klasen, F. Preijers, 2001, The Netherlands journal of medicine.

Enterovirus-induced production of pro-inflammatory and T-helper cytokines by human leukocytes.

M. Netea, J. Galama, W. Melchers, 2000, Cytokine.

A monoclonal antibody against tumour necrosis factor-alpha improves survival in experimental multiple organ dysfunction syndrome.

J. V. D. van der Meer, T. Hendriks, R. Goris, 1998, Cytokine.

Cytokine release in an ovarian carcinoma patient following intravenous administration of bispecific antibody OC/TR F(ab')2.

P. D. De Mulder, L. Massuger, J. V. D. van der Meer, 1993, Journal of the National Cancer Institute.

Can we Tackle the Antibiotic Threat?

V. ter meulen, J. V. D. van der Meer, R. Fears, 2016, European Review.

XMRV and CFS--the sad end of a story.

J. V. D. van der Meer, F. V. van Kuppeveld, 2012, Lancet.

Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes.

W. Oyen, D. Crommelin, J. Meer, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Optimizing antimicrobial therapy. A method for antimicrobial drug use evaluation.

J. Meer, I. Gyssens, B. Kullberg, 1992, The Journal of antimicrobial chemotherapy.

Low plasma concentrations of rifampicin in tuberculosis patients in Indonesia.

B. Alisjahbana, J. V. D. van der Meer, R. van Crevel, 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Globalization of Traditional Chinese Medicine: what are the issues for ensuring evidence‐based diagnosis and therapy?

D. Larhammar, V. ter meulen, J. V. D. van der Meer, 2019, Journal of internal medicine.

Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole.

J. Meis, B. Kullberg, J. V. D. van der Meer, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease.

J. V. D. van der Meer, J. W. Van 't wout, E. J. Raven, 1990, The Journal of infection.

Patterns of proinflammatory cytokines and inhibitors during typhoid fever.

J. Meer, E. Dharmana, R. Sauerwein, 1994, The Journal of infectious diseases.

Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group.

J. V. D. van der Meer, J. Vandenbroucke, E. M. de Kleijn, 1997, Medicine.

Long-term prognosis, treatment, and outcome of patients with fever of unknown origin in whom no diagnosis was made despite extensive investigation

J. V. D. van der Meer, J. van der Meer, A. Simon, 2018, Medicine.

Inquiry into the diagnostic workup of patients with fever of unknown origin.

J. V. D. van der Meer, E. M. de Kleijn, 1997, The Netherlands journal of medicine.

Fever of unknown origin (FUO). II. Diagnostic procedures in a prospective multicenter study of 167 patients. The Netherlands FUO Study Group.

J. V. D. van der Meer, H. V. van Lier, E. M. de Kleijn, 1997, Medicine.

Comment on “Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome”

M. Netea, J. Galama, J. V. D. van der Meer, 2010, Science.

Anti-toxoplasma effect of pyrimethamine, trimethoprim and sulphonamides alone and in combination: implications for therapy.

W. Melchers, J. V. D. van der Meer, A. J. van der Ven, 1996, The Journal of antimicrobial chemotherapy.

Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome.

Ivan Toni, Peter Hagoort, Floris P de Lange, 2008, Brain : a journal of neurology.

Malnutrition and socio-demographic factors associated with pulmonary tuberculosis in Timor and Rote Islands, Indonesia.

K. van der Velden, J. V. D. van der Meer, W. Dolmans, 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

High variability of TLR4 gene in different ethnic groups in Iran

M. Oosting, L. Joosten, M. Netea, 2012, Innate immunity.

Metastatic breast cancer presenting as fever, rash, and arthritis

J. Drenth, P. D. De Mulder, J. V. D. van der Meer, 1995, Cancer.

Modulation of inflammation and cytokine production by dietary (n-3) fatty acids.

M. Katan, J. V. D. van der Meer, W. Blok, 1996, The Journal of nutrition.

The Loss of Functional Caspase-12 in Europe Is a Pre-Neolithic Event

M. Netea, B. Ferwerda, S. Alonso, 2012, PloS one.

Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis.

M. Oosting, L. Joosten, M. Netea, 2010, Arthritis and rheumatism.

J. V. D. van der Meer, J. van der Ven-Jongekrijg, W. Dolmans, 2007, Asia Pacific journal of clinical nutrition.

Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis

M. Netea, M. Heijer, P. V. van Riel, 2007, Annals of the rheumatic diseases.

Does the shape of lipid A determine the interaction of LPS with Toll-like receptors?

M. Netea, J. Cavaillon, B. Kullberg, 2002, Trends in immunology.

Is a Full Recovery Possible after Cognitive Behavioural Therapy for Chronic Fatigue Syndrome?

G. Bleijenberg, H. Knoop, J. V. D. van der Meer, 2007, Psychotherapy and Psychosomatics.

Efficacy and safety of a nanofiltered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpura

J. V. D. van der Meer, J. van der Meer, T. Robak, 2011, Vox sanguinis.

Dimensional assessment of chronic fatigue syndrome.

G. Bleijenberg, J. Meer, J. V. D. van der Meer, 1994, Journal of psychosomatic research.

The epigenetic memory of monocytes and macrophages as a novel drug target in atherosclerosis.

L. Joosten, M. Netea, J. V. D. van der Meer, 2015, Clinical therapeutics.

mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity

R. Xavier, L. Joosten, C. Wijmenga, 2014, Science.

Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes.

R. Xavier, Trees Jansen, L. Jacobs, 2012, Cell host & microbe.

The influence of gastric acidity on the bio-availability of ketoconazole.

J. V. D. van der Meer, J. V. van Cutsem, J. Heykants, 1980, The Journal of antimicrobial chemotherapy.

Modulation of the pro- and anti-inflammatory cytokine balance by amphotericin B.

M. Netea, B. Kullberg, J. V. D. van der Meer, 1998, The Journal of antimicrobial chemotherapy.

Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis

M. Jaeger, M. Oosting, L. Joosten, 2014, Front. Microbiol..

Pharmacokinetics of vibunazole (BAY n 7133) administered orally to healthy subjects.

J. V. D. van der Meer, H. Mattie, J. V. van't Wout, 1985, The Journal of antimicrobial chemotherapy.

Review: infectious diseases and coagulation disorders.

J. T. ten Cate, J. V. D. van der Meer, H. ten Cate, 1999, The Journal of infectious diseases.

Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction.

L. Jacobs, M. Netea, B. Kullberg, 2003, The Journal of infectious diseases.

Modulation of the pro- and antiinflammatory cytokines by amphotericin B.

M. Netea, B. Kullberg, J. V. D. van der Meer, 1999, The Journal of infectious diseases.

A guiding map for inflammation

Richard Hotchkiss, Michael T Heneka, Alberto Mantovani, 2017, Nature Immunology.

Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic?

T. Vree, J. V. D. van der Meer, A. J. van der Ven, 1995, AIDS.

Indium-111-labeled polyclonal human immunoglobulin: identifying focal infection in patients positive for human immunodeficiency virus.

W. Oyen, R. Miller, P. Ell, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Tuberculosis cutis miliaris disseminata as a manifestation of miliary tuberculosis: literature review and report of a case of recurrent skin lesions.

F. Smedts, R. Rietbroek, J. V. D. van der Meer, 1991, Reviews of infectious diseases.

Drug intolerance in HIV disease.

T. Vree, J. V. D. van der Meer, A. J. van der Ven, 1994, The Journal of antimicrobial chemotherapy.

Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors.

Claire Collins, Trees Jansen, L. Jacobs, 2006, The Journal of clinical investigation.

Persistence of Salmonellae in Blood and Bone Marrow: Randomized Controlled Trial Comparing Ciprofloxacin and Chloramphenicol Treatments against Enteric Fever

J. V. D. van der Meer, J. van der Ven-Jongekrijg, W. Dolmans, 2003, Antimicrobial Agents and Chemotherapy.

The macrophage mannose receptor induces IL-17 in response to Candida albicans.

Irma Joosten, L. Joosten, M. Netea, 2009, Cell host & microbe.

Variable expression and treatment of PAPA syndrome

E. Hoppenreijs, J. V. D. van der Meer, A. Simon, 2011, Annals of the rheumatic diseases.

Physiology and Pharmacology of Temperature Regulation Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes

J. Meer, J. V. D. van der Meer, A. Simon, 2006 .

Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution.

J. V. D. van der Meer, J. V. D. Meer, J. C. H. Hilst, 2002, The Netherlands journal of medicine.

Interleukin-1-induced nonspecific resistance to bacterial infection in mice is not mediated by glucocorticosteroids

C. Sweep, J. V. D. van der Meer, M. Vogels, 1992, Antimicrobial Agents and Chemotherapy.

From the Th1/Th2 Paradigm towards a Toll-Like Receptor/T-Helper Bias

M. Netea, G. Adema, B. Kullberg, 2005, Antimicrobial Agents and Chemotherapy.

IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans

R. Xavier, S. Smeekens, L. Joosten, 2014, Proceedings of the National Academy of Sciences.

Toll-Like Receptor 2 Suppresses Immunity against Candida albicans through Induction of IL-10 and Regulatory T Cells

M. Netea, T. Hartung, G. Adema, 2004, The Journal of Immunology.

[Drug reactions occur frequently in patients with HIV infection].

T. Vree, J. V. D. van der Meer, P. Koopmans, 1995, Nederlands tijdschrift voor geneeskunde.

The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans.

L. Joosten, M. Netea, B. Kullberg, 2010, Vaccine.

Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis.

A. Hoischen, S. Smeekens, L. Joosten, 2011, The New England journal of medicine.

Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions.

J. Meis, J. V. D. van der Meer, M. Deuren, 1993, BMJ.

Decreased plasma leptin concentrations in tuberculosis patients are associated with wasting and inflammation.

M. Netea, J. V. D. van der Meer, C. West, 2002, The Journal of clinical endocrinology and metabolism.

Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: a Retrospective Cohort Study

S. Smeekens, M. Jaeger, M. Oosting, 2020, Cell Reports Medicine.

STAT1 Hyperphosphorylation and Defective IL12R/IL23R Signaling Underlie Defective Immunity in Autosomal Dominant Chronic Mucocutaneous Candidiasis

A. Hoischen, S. Smeekens, L. Joosten, 2011, PloS one.

The Candida Th17 response is dependent on mannan- and beta-glucan-induced prostaglandin E2.

S. Smeekens, L. Joosten, M. Netea, 2010, International immunology.

Aspergillus infection in patients with hyperimmunoglobulin E syndrome.

L. Bont, J. V. D. van der Meer, J. Verhage, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acyclovir in severe herpes virus infections.

J. V. D. van der Meer, J. Versteeg, 1982, The American journal of medicine.

Inflammasome-independent regulation of IL-1-family cytokines.

L. Joosten, M. Netea, C. Dinarello, 2015, Annual review of immunology.

Toll-like receptors as an escape mechanism from the host defense.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2004, Trends in microbiology.

Peritoneal tuberculosis in two young immigrants with fever of unknown origin.

J. V. D. van der Meer, S. Vreden, B. J. Brenninkmeijer, 1992, The Netherlands journal of medicine.

Antibiotic use: how to improve it?

R. Grol, M. Hulscher, J. V. D. van der Meer, 2010, International journal of medical microbiology : IJMM.

Cutaneous hyperpigmentation induced by doxycycline: a case series.

J. V. D. van der Meer, M. V. van Kasteren, M. V. van Rossum, 2015, The Netherlands journal of medicine.

Defining trained immunity and its role in health and disease

R. Xavier, L. Joosten, M. Netea, 2020, Nature Reviews Immunology.

Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity

R. Xavier, L. Joosten, C. Wijmenga, 2014, Science.

Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections.

R. Sauerwein, J. V. D. van der Meer, M. Deuren, 1994, The Journal of infectious diseases.

Yersinia enterocolitica and the chronic fatigue syndrome.

G. Bleijenberg, J. V. D. van der Meer, J. Vercoulen, 1998, The Journal of infection.

Elevated serum level and altered glycosylation of alpha 1-acid glycoprotein in hyperimmunoglobulinemia D and periodic fever syndrome: evidence for persistent inflammation.

J. V. D. van der Meer, J. van der Meer, E. C. van Ommen, 1995, Clinical immunology and immunopathology.

Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.

W. Oyen, J. Meer, G. Storm, 2000, The Journal of pharmacology and experimental therapeutics.

Skin Microbiome Imbalance in Patients with STAT1/STAT3 Defects Impairs Innate Host Defense Responses

C. Huttenhower, D. Gevers, R. Xavier, 2013, Journal of Innate Immunity.

Genetic Variation in Pattern Recognition Receptors and Adaptor Proteins Associated With Development of Chronic Q Fever.

L. Joosten, M. Netea, J. V. D. van der Meer, 2015, The Journal of infectious diseases.

Anti‐SSA antibodies are present in immunoglobulin preparations

J. V. D. van der Meer, P. Strengers, D. Hamann, 2015, Transfusion.

Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency.

A. Schäffer, H. Cao, P. Browett, 2015, American journal of human genetics.

Innate immune memory: An evolutionary perspective

M. Netea, J. V. D. van der Meer, U. Conrath, 2018, Immunological reviews.

Sequential therapy with intravenous and oral cephalosporins.

J. V. D. van der Meer, R. Janknegt, 1994, The Journal of antimicrobial chemotherapy.

Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort

M. Netea, G. Bleijenberg, J. Galama, 2010, BMJ : British Medical Journal.

Biological and biochemical characterization of clinical isolates of herpes simplex virus type 2 resistant to acyclovir

J. V. D. van der Meer, P. Collins, N. Oliver, 1989, Antimicrobial Agents and Chemotherapy.

Treatment of eczema herpeticum with acyclovir.

J. V. D. van der Meer, B. Vermeer, J. Versteeg, 1983, Archives of dermatology.

Hanta virus infection during dengue virus infection outbreak in Indonesia.

J. V. D. van der Meer, S. Hadisaputro, W. Dolmans, 2009, Acta medica Indonesiana.

Clinical infections and nonsurgical treatment of parapharyngeal space infections complicating throat infection.

A. V. D. van der Mey, G. Meerdink, J. V. D. van der Meer, 1989, Reviews of infectious diseases.

Autophagy Modulates Borrelia burgdorferi-induced Production of Interleukin-1β (IL-1β)*

R. Xavier, M. Oosting, L. Joosten, 2013, The Journal of Biological Chemistry.

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.

P. Weber, M. Klempner, E. Schaefer, 1989, The New England journal of medicine.

Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis.

L. Joosten, M. Netea, W. B. van den Berg, 2007, Arthritis and rheumatism.

Inflammatory responses to infection: The Dutch contribution

M. Nolte, J. V. D. van der Meer, 2014, Immunology Letters.

The Changing Burden of Infectious Disease in Europe

V. ter meulen, J. V. D. van der Meer, R. Fears, 2011, Science Translational Medicine.

Dietary n-3 fatty acids increase spleen size and postendotoxin circulating TNF in mice; role of macrophages, macrophage precursors, and colony-stimulating factor-1.

J. Meer, W. Buurman, W. Eling, 1996, Journal of immunology.

A novel splice variant of FcγRIIa: a risk factor for anaphylaxis in patients with hypogammaglobulinemia.

T. K. van den Berg, T. Kuijpers, J. V. D. van der Meer, 2013, The Journal of allergy and clinical immunology.

Presence of Genetic Variants Among Young Men With Severe COVID-19.

J. Schuurs-Hoeijmakers, A. Hoischen, M. Jaeger, 2020, JAMA.

Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immunoglobulin G.

W. Oyen, R. Goris, J. V. D. van der Meer, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk.

M. Netea, P. V. van Riel, J. V. D. van der Meer, 2007, Journal of lipid research.

Preferential localization of systemically administered radiolabeled interleukin 1alpha in experimental inflammation in mice by binding to the type II receptor.

W. Oyen, J. V. D. van der Meer, O. Boerman, 1997, The Journal of clinical investigation.

A single low dose of human recombinant interleukin 1 accelerates the recovery of neutrophils in mice with cyclophosphamide-induced neutropenia.

J. Falkenburg, C. Dinarello, P. Kluin, 1989, Experimental hematology.

Early interferon-gamma response against Plasmodium falciparum correlates with interethnic differences in susceptibility to parasitemia between sympatric Fulani and Dogon in Mali.

O. Doumbo, R. Sauerwein, J. V. D. van der Meer, 2010, The Journal of infectious diseases.

Role of TLR1 and TLR6 in the host defense against disseminated candidiasis.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2008, FEMS immunology and medical microbiology.

Adverse reactions to co-trimoxazole in HIV infection: a reappraisal of the glutathione-hydroxylamine hypothesis.

T. Vree, J. V. D. van der Meer, A. J. van der Ven, 1996, The Journal of antimicrobial chemotherapy.

Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole.

T. Vree, J. V. D. van der Meer, A. J. van der Ven, 1995, British journal of clinical pharmacology.

Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment.

G. Bleijenberg, J. Meer, J. Prins, 2000, Journal of psychosomatic research.

Physical activity in chronic fatigue syndrome: assessment and its role in fatigue.

G. Bleijenberg, O. Hommes, P. Jongen, 1997, Journal of psychiatric research.

Plasma and whole blood exchange in meningococcal sepsis.

R. Sauerwein, J. V. D. van der Meer, M. Deuren, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy.

J. V. D. van der Meer, P. J. van den Broek, H. Eijkhout, 2003, The Netherlands journal of medicine.

Use of immune modulators in nonspecific therapy of bacterial infections

J. V. D. van der Meer, M. Vogels, J.W.M. van der Meer, 1992, Antimicrobial Agents and Chemotherapy.

[Cytokines in the pathogenesis of fever].

C. Dinarello, J. V. D. van der Meer, S. Endres, 1989, Der Internist.

Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction

W. Oyen, J. V. D. van der Meer, O. Boerman, 1998, European Journal of Nuclear Medicine.

Pneumococcal bacteremia in adults over a 10-year period at University Hospital, Leiden.

J. Hermans, J. V. D. van der Meer, G. Bruyn, 1988, Reviews of infectious diseases.

Guidelines for the prevention of antimicrobial resistance in hospitals.

B. Kullberg, J. V. D. van der Meer, M. V. van Kasteren, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recurrent cystitis and bladder mass in two adults with chronic granulomatous disease.

J. V. D. van der Meer, F. Southwick, 1988, Annals of internal medicine.

Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities.

J. Meer, B. Kullberg, J. V. D. van der Meer, 2000, The Journal of infectious diseases.

Circulating Lipoproteins Are a Crucial Component of Host Defense against Invasive Salmonella typhimurium Infection

L. Joosten, M. Netea, B. Kullberg, 2009, PloS one.

Diagnosis of bone, joint, and joint prosthesis infections with In-111-labeled nonspecific human immunoglobulin G scintigraphy.

W. Oyen, J. V. van Horn, J. V. D. van der Meer, 1992, Radiology.

Hip and knee arthroplasty infection. In-111-IgG scintigraphy in 102 cases.

W. Oyen, J. V. D. van der Meer, M. Nijhof, 1997, Acta orthopaedica Scandinavica.

Utility of indium-111-labeled polyclonal immunoglobulin G scintigraphy in fever of unknown origin. The Netherlands FUO Imaging Group.

W. Oyen, J. V. D. van der Meer, F. Corstens, 1997, Journal of Nuclear Medicine.

Utility of scintigraphic methods in patients with fever of unknown origin.

W. Oyen, J. V. D. van der Meer, F. Corstens, 1995, Archives of internal medicine.

Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy.

W. Oyen, J. V. D. van der Meer, F. Corstens, 2004, European journal of nuclear medicine and molecular imaging.

Diagnosing prosthetic joint infection.

W. Oyen, J. V. van Horn, J. V. D. van der Meer, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Fever of unknown origin (FUO): report on 53 patients in a Dutch university hospital.

J. V. D. van der Meer, E. M. de Kleijn, 1995, The Netherlands journal of medicine.

Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time.

W. Oyen, J. V. D. van der Meer, O. Boerman, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A comparison of patients with Q fever fatigue syndrome and patients with chronic fatigue syndrome with a focus on inflammatory markers and possible fatigue perpetuating cognitions and behaviour.

M. Netea, G. Bleijenberg, H. Knoop, 2015, Journal of psychosomatic research.

Towards a role of interleukin-32 in atherosclerosis.

L. Joosten, M. Netea, C. Dinarello, 2013, Cytokine.

Innate Immunity to Mycobacterium tuberculosis

T. Ottenhoff, J. V. D. van der Meer, R. van Crevel, 2002, Clinical Microbiology Reviews.

TNFalpha and IL-1beta exert no direct vasoactivity in human isolated resistance arteries.

M. Netea, J. V. D. van der Meer, P. Pickkers, 2002, Cytokine.

Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome.

J. Schalkwijk, J. V. D. van der Meer, H. D. de Koning, 2011, The Journal of allergy and clinical immunology.

Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta.

L. Joosten, M. Netea, G. Fantuzzi, 2009, Arthritis and rheumatism.

Defects of pattern recognition: primary immunodeficiencies of the innate immune system.

M. Netea, J. V. D. van der Meer, M. van Deuren, 2011, Current opinion in pharmacology.

Immunodeficiency and genetic defects of pattern-recognition receptors.

M. Netea, J. V. D. van der Meer, 2011, The New England journal of medicine.

Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice

W. Eling, J. V. D. van der Meer, M. Vogels, 1994, Infection and immunity.

IL-1β Processing in Host Defense: Beyond the Inflammasomes

Leo A. B. Joosten, Mihai G. Netea, L. Joosten, 2010, PLoS pathogens.

Immunogenicity of the Q fever skin test.

L. Joosten, M. Netea, J. V. D. van der Meer, 2014, Journal of Infection.

Activation of the cytokine network in familial Mediterranean fever.

D. Zemer, M. Pras, J. V. D. van der Meer, 1999, The Journal of rheumatology.

Impaired fibrinolysis in the pathogenesis of dengue hemorrhagic fever

J. V. D. van der Meer, C. Hack, W. Dolmans, 2002, Journal of medical virology.

Tuberculous meningitis: is a 6-month treatment regimen sufficient?

A. Verbeek, J. V. D. van der Meer, J. V. van Loenhout-Rooyackers, 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Beneficial response to anakinra and thalidomide in Schnitzler’s syndrome

M. Netea, J. V. D. van der Meer, H. D. de Koning, 2005, Annals of the rheumatic diseases.

Case 39-2014: A girl with Crohn's disease and pulmonary nodules.

M. Netea, J. V. D. van der Meer, F. L. van de Veerdonk, 2015, The New England journal of medicine.

Limited humoral and cellular responses to Q fever vaccination in older adults with risk factors for chronic Q fever.

L. Joosten, M. Netea, J. V. D. van der Meer, 2013, The Journal of infection.

Specific interferon γ detection for the diagnosis of previous Q fever.

L. Joosten, M. Netea, J. V. D. van der Meer, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vascular proliferation as an unusual cause of hemorrhagic diathesis in myelofibrosis.

E. Vellenga, J. V. D. van der Meer, F. Albeda, 1991, American journal of clinical pathology.

[Clinical reasoning and decision making in practice. A man with pneumonia and ill smelling watery sputum: the truth revealed after 80 years].

J. V. D. van der Meer, A. Overbeke, W. Hart, 2003, Nederlands tijdschrift voor geneeskunde.

Effectiveness of Long-term Doxycycline Treatment and Cognitive-Behavioral Therapy on Fatigue Severity in Patients with Q Fever Fatigue Syndrome (Qure Study): A Randomized Controlled Trial

G. Bleijenberg, H. Knoop, R. Donders, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

TLR1/TLR2 Heterodimers Play an Important Role in the Recognition of Borrelia Spirochetes

M. Oosting, L. Joosten, M. Netea, 2011, PloS one.

Hereditary periodic fever.

J. Drenth, J. V. D. van der Meer, J. Drenth, 2001, The New England journal of medicine.

Cytokine patterns during dengue shock syndrome.

J. V. D. van der Meer, C. Hack, W. Dolmans, 2003, European cytokine network.

Cognitive Behaviour Group Therapy for Chronic Fatigue Syndrome: A Non-Randomised Waiting List Controlled Study

G. Bleijenberg, E. Bazelmans, J. Prins, 2005, Psychotherapy and Psychosomatics.

Fatigue and chronic fatigue syndrome-like complaints in the general population.

A. Verbeek, G. Bleijenberg, G. Zielhuis, 2010, European journal of public health.

The challenge of Lyme disease: tired of the Lyme wars.

B. Kullberg, J. V. D. van der Meer, A. Berende, 2011, The Netherlands journal of medicine.

Role of NOD1 polymorphism in susceptibility and clinical progression of rheumatoid arthritis.

L. Joosten, M. Netea, P. V. van Riel, 2013, Rheumatology.

NOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosis

M. Netea, S. Girardin, D. D. de Jong, 2005, PLoS pathogens.

Dynamic Changes in Pro- and Anti-Inflammatory Cytokine Profiles and Gamma Interferon Receptor Signaling Integrity Correlate with Tuberculosis Disease Activity and Response to Curative Treatment

B. Alisjahbana, T. Ottenhoff, T. de Boer, 2006, Infection and Immunity.

Genomewide association study of leprosy.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2010, The New England journal of medicine.

Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1beta production by the fungal pathogen Candida albicans.

L. Joosten, M. Netea, N. Gow, 2009, The Journal of infectious diseases.

Dysregulation of innate immunity: hereditary periodic fever syndromes

J. Drenth, J. V. D. van der Meer, A. Simon, 2009, British journal of haematology.

The role of NLRs and TLRs in the activation of the inflammasome

L. Joosten, M. Netea, B. Kullberg, 2008 .

Innate immunity networks during infection with Borrelia burgdorferi

M. Oosting, L. Joosten, M. Netea, 2014, Critical reviews in microbiology.

The role of endogenous interleukin (IL)-18, IL-12, IL-1beta, and tumor necrosis factor-alpha in the production of interferon-gamma induced by Candida albicans in human whole-blood cultures.

M. Netea, C. Dinarello, Soohyun Kim, 2002, The Journal of infectious diseases.

Depression of plasma levels of cytokines and ex-vivo cytokine production in relation to the activity of the pituitary-adrenal axis, in patients undergoing major vascular surgery.

C. Sweep, J. V. D. van der Meer, A. Naber, 1999, Cytokine.

Anakinra for the inflammatory complications of chronic granulomatous disease.

M. Netea, C. Dinarello, J. V. D. van der Meer, 2011, The Netherlands journal of medicine.

Functional and morphological monocyte abnormalities in a patient with malakoplakia.

J. Meis, J. V. D. van der Meer, J. Curfs, 1998, The American journal of medicine.

Modulation of Toll-Like Receptor 2 (TLR2) and TLR4 Responses by Aspergillus fumigatus

L. Joosten, M. Netea, J. Latgé, 2009, Infection and Immunity.

Bartonella quintana Lipopolysaccharide Is a Natural Antagonist of Toll-Like Receptor 4

L. Joosten, M. Netea, W. B. van den Berg, 2007, Infection and Immunity.

Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia.

J. Hautvast, J. V. D. van der Meer, W. Schultink, 2000, The Journal of nutrition.

Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial

L. Joosten, M. Netea, H. Knoop, 2015, Trials.

Social aspects of patients with pulmonary tuberculosis in Indonesia.

J. V. D. van der Meer, W. Dolmans, C. West, 2002, The Southeast Asian journal of tropical medicine and public health.

Diagnosis of Coxiella burnetii Infection: Comparison of a Whole Blood Interferon-Gamma Production Assay and a Coxiella ELISPOT

J. V. D. van der Meer, M. van Deuren, T. Sprong, 2014, PloS one.

Antibiotic prescribing in hospitals: a social and behavioural scientific approach.

R. Grol, M. Hulscher, J. V. D. van der Meer, 2010, The Lancet. Infectious diseases.

Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice.

M. Netea, W. Buurman, B. Kullberg, 1995, The Journal of infectious diseases.

Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis

L. Joosten, M. Netea, D. Philpott, 2008, Proceedings of the National Academy of Sciences.

Mycobacterium paratuberculosis is recognized by Toll‐like receptors and NOD2

M. Netea, S. Girardin, T. Ottenhoff, 2007, Journal of leukocyte biology.

Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome.

G. Bleijenberg, F. Miedema, J. Meer, 1996, The Journal of infectious diseases.

Epstein-Barr virus (EBV) and the chronic fatigue syndrome: normal virus load in blood and normal immunologic reactivity in the EBV regression assay.

G. Bleijenberg, J. V. D. van der Meer, J. Vercoulen, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recurrent erysipelas despite antibiotic prophylaxis: an analysis from case studies.

B. Kullberg, J. V. D. van der Meer, J. B. Koster, 2007, The Netherlands journal of medicine.

Cytokine Inhibition in Patients With Chronic Fatigue Syndrome

J. V. D. van der Meer, M. Roerink, 2017, Annals of Internal Medicine.

Cytokine Inhibition in Patients With Chronic Fatigue Syndrome

H. Knoop, C. Dinarello, J. V. D. van der Meer, 2017, Annals of Internal Medicine..

Interleukin-1 as a mediator of fatigue in disease: a narrative review

H. Knoop, M. E. van der Schaaf, C. Dinarello, 2017, Journal of Neuroinflammation.

Chronic fatigue syndrome

J. V. D. van der Meer, 1997, European journal of clinical investigation.

The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases

L. Joosten, M. Netea, Melissa D. Johnson, 2014, BMC Immunology.

Recognition of pathogenic microorganisms by Toll-like receptors.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2006, Drugs of today.

Epstein-Barr virus infection and Hodgkin's disease.

J. V. D. van der Meer, C. J. Doorenbos, D. Zanen, 1986, Annals of internal medicine.

Scintigraphic evaluation of experimental colitis in rabbits.

W. Oyen, J. Meer, G. Storm, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Mast Cells Induce Vascular Smooth Muscle Cell Apoptosis via a Toll-Like Receptor 4 Activation Pathway

L. Joosten, M. Netea, J. V. D. van der Meer, 2012, Arteriosclerosis, thrombosis, and vascular biology.

Defective interferon-gamma production in patients with hairy cell leukaemia.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2008, The Netherlands journal of medicine.

Acute renal failure associated with paracetamol ingestion in an alcoholic patient.

J. V. D. van der Meer, J. Drenth, E. Wuis, 1994, Nephron.

Natural course of symptoms in Cambodia veterans: a follow-up study

G. Bleijenberg, J. V. D. van der Meer, P. Soetekouw, 2001, Psychological Medicine.

Fatigue in Cambodia veterans.

G. Bleijenberg, J. V. D. van der Meer, P. Soetekouw, 2000, QJM : monthly journal of the Association of Physicians.

Candida-specific interferon-gamma deficiency and toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis.

M. Netea, B. Kullberg, J. V. D. van der Meer, 2003, The Netherlands journal of medicine.

Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression.

Pilar Barrera, L. Joosten, M. Netea, 2003, Arthritis and rheumatism.

Long-Term Follow-Up, Clinical Features, and Quality of Life in a Series of 103 Patients With Hyperimmunoglobulinemia D Syndrome

J. Drenth, J. V. D. van der Meer, A. Simon, 2008, Medicine.

Hyper-IgD syndrome and pregnancy.

J. V. D. van der Meer, J. Drenth, J. D. de Hullu, 1996, European journal of obstetrics, gynecology, and reproductive biology.

TLR2/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome.

J. V. D. van der Meer, A. Simon, T. Remijn, 2015, Rheumatology.

A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative.

W. Oyen, J. Meer, G. Storm, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Circulating and ex vivo production of pyrogenic cytokines and interleukin-1 receptor antagonist in 123 patients with fever of unknown origin. The Netherlands Fever of Unknown Origin Study Group.

J. V. D. van der Meer, P. Demacker, J. Drenth, 1997, Journal of Infectious Diseases.

The anti-CD20 antibody rituximab reduces the Th17 cell response.

L. Joosten, M. Netea, F. D. Di Padova, 2011, Arthritis and rheumatism.

TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans

M. Netea, O. Doumbo, H. Brunner, 2007, Proceedings of the National Academy of Sciences.

Pathogenesis of fever: are circulating pyrogenic cytokines the only mediators?

M. Netea, B. Kullberg, J. V. D. van der Meer, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Is somatostatin receptor scintigraphy suited to detection of acute infectious disease?

W. Oyen, J. V. D. van der Meer, O. Boerman, 1994, Nuclear medicine communications.

Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.

M. Netea, Y. Iwakura, B. Kullberg, 2006, The Journal of infectious diseases.

Cost-effectiveness of cognitive behaviour therapy for patients with chronic fatigue syndrome.

G. Bleijenberg, J. Prins, J. Prins, 2004, QJM : monthly journal of the Association of Physicians.

Chronic yersiniosis due to defects in the TLR5 and NOD2 recognition pathways.

L. Joosten, M. Netea, D. Jong, 2010, The Netherlands journal of medicine.

[Chronic fatigue syndrome. II. Psychosocial hypothesis].

G. Bleijenberg, J. V. D. van der Meer, J. Vercoulen, 1991, Nederlands tijdschrift voor geneeskunde.

The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects.

G. Bleijenberg, O. Hommes, P. Jongen, 1996, Archives of neurology.

Mediation analysis shows that a decline in self-efficacy mediates the increase in fatigue severity following an initial positive response to cognitive behavioural therapy in Q fever fatigue syndrome.

G. Bleijenberg, H. Knoop, J. V. D. van der Meer, 2019, Journal of psychosomatic research.

The effect of ondansetron, a 5-HT3 receptor antagonist, in chronic fatigue syndrome: a randomized controlled trial.

J. Buitelaar, G. Bleijenberg, J. V. D. van der Meer, 2010, The Journal of clinical psychiatry.

Physical activity and exercise performance in symptomatic Cambodia veterans.

G. Bleijenberg, H. Folgering, J. V. D. van der Meer, 2002, QJM : monthly journal of the Association of Physicians.

Is physical deconditioning a perpetuating factor in chronic fatigue syndrome? A controlled study on maximal exercise performance and relations with fatigue, impairment and physical activity

G. Bleijenberg, H. Folgering, E. Bazelmans, 2001, Psychological Medicine.

The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model.

G. Bleijenberg, O. Hommes, P. Jongen, 1998, Journal of psychosomatic research.

Tissue- and Time-Dependent Upregulation of Cytokine mRNA in a Murine Model for the Multiple Organ Dysfunction Syndrome

R. Goris, J. V. D. van der Meer, T. Hendriks, 2004, Annals of surgery.

Comment on “Power of Rare Diseases: Found in Translation”

C. Dinarello, J. V. D. van der Meer, A. Simon, 2014, Science Translational Medicine.

Swelling of hand and forearm caused by Mycobacterium bovis.

J. Meis, J. V. D. van der Meer, A. J. van der Ven, 1999, The Netherlands journal of medicine.

HLA-DRB1*12 is associated with protection against complicated typhoid fever, independent of tumour necrosis factor alpha.

E. Dharmana, I. Joosten, J. V. D. van der Meer, 2002, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Human lipoproteins have divergent neutralizing effects on E. coli LPS, N. meningitidis LPS, and complete Gram-negative bacteria Published, JLR Papers in Press, February 1, 2004. DOI 10.1194/jlr.M300453-JLR200

L. Jacobs, M. Netea, J. V. D. van der Meer, 2004, Journal of Lipid Research.

Dietary fish-oil supplementation in experimental gram-negative infection and in cerebral malaria in mice.

J. Meer, W. Buurman, W. Eling, 1992, The Journal of infectious diseases.

The role of post-traumatic stress disorder symptoms in fatigued Cambodia veterans.

G. Bleijenberg, J. V. D. van der Meer, P. Soetekouw, 2002, Military medicine.

Regulation of the production of pro-inflammatory cytokines and antagonists during chemotherapy-induced neutropenia in patients with haematological malignancies.

J. Raemaekers, J. Drenth, B. Kullberg, 1997, Cytokine.

Complement plays a central role in Candida albicans‐induced cytokine production by human PBMCs

L. Joosten, M. Netea, Shih-Chin Cheng, 2012, European journal of immunology.

Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia

R. Xavier, S. Smeekens, L. Joosten, 2014, Nature Communications.

Human genetic susceptibility to Candida infections.

L. Joosten, M. Netea, W. Scott, 2012, Medical mycology.

Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection.

M. Netea, M. den Heijer, S. Morré, 2006, European cytokine network.

Immunologic defects in severe mucocutaneous HSV-2 infections: Response to IFN-γ therapy.

A. Hoischen, M. Huynen, M. Netea, 2016, The Journal of allergy and clinical immunology.

Whole‐blood cultures: a valid and reliable tool for studying cytokines in exercise

J. V. D. van der Meer, J. Drenth, 1999, European journal of clinical investigation.

Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice.

J. Meer, J. V. D. van der Meer, A. Dofferhoff, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Inhibition of Plasmodium berghei liver schizont development and reduction of cytokine production capacity in rats by dietary fish oil supplementation.

J. Verhave, R. Sauerwein, M. Oettinger, 1995, The American journal of tropical medicine and hygiene.

LPS-induced release of IL-1 beta, IL-1Ra, IL-6, and TNF-alpha in whole blood from patients with familial hypercholesterolemia: no effect of cholesterol-lowering treatment.

M. Netea, J. V. D. van der Meer, P. Demacker, 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Genetic variation in the dectin-1/CARD9 recognition pathway and susceptibility to candidemia.

M. Oosting, L. Joosten, M. Netea, 2011, The Journal of infectious diseases.

Periodic fever associated with intermittent rhythmic delta activity: a syndrome of hypothalamic origin?

J. G. van Dijk, J. V. D. van der Meer, F. Roelfsema, 1997, Electroencephalography and clinical neurophysiology.

Earlier initiation of antibiotic treatment for severe infections after interventions to improve the organization and specific guidelines in the emergency department.

J. Meis, B. Kullberg, J. V. D. van der Meer, 2000, Archives of internal medicine.

Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study

R. Grol, M. Hulscher, B. Kullberg, 2007, Quality and Safety in Health Care.

Disseminated gonococcal infection in elderly patients.

J. V. D. van der Meer, J. Poolman, C. Mulder, 1986, Archives of internal medicine.

Effort but not Reward Sensitivity is Altered by Acute Sickness Induced by Experimental Endotoxemia in Humans

M. Husain, M. E. van der Schaaf, J. V. D. van der Meer, 2017, Neuropsychopharmacology.

Antibiotic control measures in Dutch secondary care hospitals.

R. Grol, M. Hulscher, J. V. D. van der Meer, 2005, The Netherlands journal of medicine.

Toll-like receptor 1 polymorphisms increase susceptibility to candidemia.

M. Oosting, L. Joosten, M. Netea, 2012, The Journal of infectious diseases.

The Evolutionary History of TLR4 Polymorphisms in Europe

L. Joosten, M. Netea, S. Alonso, 2011, Journal of Innate Immunity.

Phospholipase A2 is a circulating mediator in typhoid fever.

C. Schalkwijk, E. Dharmana, B. Kullberg, 1995, The Journal of infectious diseases.

Evolution of cytokine production capacity in ancient and modern European populations

M. Jaeger, L. Joosten, M. Netea, 2021, bioRxiv.

Aspergillus fumigatus–Induced IL-22 Is Not Restricted to a Specific Th Cell Subset and Is Dependent on Complement Receptor 3

S. Smeekens, L. Joosten, M. Netea, 2013, The Journal of Immunology.

Quality of antibiotic use for lower respiratory tract infections at hospitals: (how) can we measure it?

R. Grol, M. Hulscher, B. Kullberg, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Hyperimmunoglobulin D syndrome].

A. Prieur, J. V. D. van der Meer, J. Drenth, 1995, Presse medicale.

Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19.

L. Joosten, M. Netea, C. Maas, 2021, The Journal of infectious diseases.

The role of NLRs and TLRs in the activation of the inflammasome.

L. Joosten, M. Netea, B. Kullberg, 2008, Expert Opinion on Biological Therapy.

[Rupture of the spleen in primary amyloidosis].

J. V. D. van der Meer, A. A. Mosmans-Smits, 1973, Nederlandsch tijdschrift voor geneeskunde.

Labelled Stealth liposomes in experimental infection: an alternative to leukocyte scintigraphy?

W. Oyen, D. Crommelin, J. V. D. van der Meer, 1996, Nuclear medicine communications.

Role of Interleukin-23 (IL-23) Receptor Signaling for IL-17 Responses in Human Lyme Disease

M. Oosting, L. Joosten, M. Netea, 2011, Infection and Immunity.

Native LDL potentiate TNF alpha and IL-8 production by human mononuclear cells.

L. Jacobs, M. Netea, B. Kullberg, 2002, Journal of lipid research.

Circulating concentrations and production of cytokines and soluble receptors in rheumatoid arthritis patients: effects of a single dose methotrexate.

J. V. D. van der Meer, L. van de Putte, P. Demacker, 1994, British journal of rheumatology.

Dengue disease severity in Indonesian children: an evaluation of the World Health Organization classification system.

A. Osterhaus, J. V. D. van der Meer, E. V. van Gorp, 2007, BMC infectious diseases.

The effect of granisetron, a 5-HT3 receptor antagonist, in the treatment of chronic fatigue syndrome patients--a pilot study.

G. Bleijenberg, J. V. D. van der Meer, G. K. The, 2003, Netherlands Journal of Medicine.

Intact interferon-γ response against Coxiella burnetii by peripheral blood mononuclear cells in chronic Q fever.

M. Netea, J. Mege, J. V. D. van der Meer, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

How the COVID-19 pandemic highlights the necessity of animal research

L. Joosten, M. Netea, K. van Oers, 2020, Current Biology.

How the COVID-19 pandemic highlights the necessity of animal research

L. Joosten, M. Netea, K. van Oers, 2020, Current Biology.

BCG vaccination in healthcare providers and the protection against COVID-19.

M. Netea, J. V. D. van der Meer, R. van Crevel, 2020, The Journal of clinical investigation.

Interferon-γ and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome

L. Joosten, M. Netea, J. V. D. van der Meer, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Specific in vitro interferon-gamma and IL-2 production as biomarkers during treatment of chronic Q fever

M. Netea, J. V. D. van der Meer, M. van Deuren, 2015, Front. Microbiol..

Pro-inflammatory cytokine response in acute infection.

M. Netea, B. Alisjahbana, J. V. D. van der Meer, 2003, Advances in experimental medicine and biology.

Independent medical research.

M. Katan, J. V. D. van der Meer, W. van Swaaij, 2007, The Netherlands journal of medicine.

Hemodynamic and neurohumoral responses to head-up tilt in patients with chronic fatigue syndrome

G. Bleijenberg, W. Wieling, J. V. D. van der Meer, 2002, Clinical Autonomic Research.

Bartonella quintana lipopolysaccharide (LPS): structure and characteristics of a potent TLR4 antagonist for in-vitro and in-vivo applications

L. Joosten, M. Netea, J. V. D. van der Meer, 2016, Scientific Reports.

Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment

L. Joosten, E. Bronkhorst, H. Knoop, 2017, Journal of Translational Medicine.

Translational Medicine Policy Issues in Infectious Disease

V. ter meulen, J. V. D. van der Meer, R. Fears, 2010, Science Translational Medicine.

A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome

L. Joosten, M. Netea, R. ter Horst, 2019, Journal of Translational Medicine.

The Impact of Central and Peripheral Cyclooxygenase Enzyme Inhibition on Exercise-Induced Elevations in Core Body Temperature.

M. Netea, M. Hopman, T. Eijsvogels, 2017, International journal of sports physiology and performance.

Prolonged bleeding time during azlocillin therapy.

B. Dijkmans, J. V. D. van der Meer, H. Mattie, 1980, The Journal of antimicrobial chemotherapy.

Inflammatory mediators in children with protein-energy malnutrition.

B. Lowe, K. Marsh, N. Peshu, 1997, The American journal of clinical nutrition.

Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors.

R. Grol, M. Hulscher, I. Gyssens, 2005, The Journal of antimicrobial chemotherapy.

[Prevalence of chronic fatigue syndrome and primary fibromyalgia syndrome in The Netherlands].

C. van Weel, G. Bleijenberg, E. Bazelmans, 1997, Nederlands tijdschrift voor geneeskunde.

Tryptophan depletion in chronic fatigue syndrome, a pilot cross-over study

J. Buitelaar, G. Bleijenberg, R. Verkes, 2014, BMC Research Notes.

Relapsing hepatitis due to cytomegalovirus?

J. Galama, J. V. D. van der Meer, I. V. van Munster, 1991, The Journal of infection.

Association of Mal/TIRAP S180L variant polymorphism with decreased infection risk in patients with advanced HIV-1 infection.

M. Netea, V. Sakka, B. Ferwerda, 2012, Cytokine.

Cutaneous reactions to trimethoprim-sulphametrole in AIDS patients treated for Pneumocystis carinii pneumonia.

T. Vree, J. V. D. van der Meer, P. Koopmans, 1996, AIDS.

Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm.

W. Oyen, J. V. D. van der Meer, O. Boerman, 1998, Nuclear medicine communications.

The influence of dietary fish-oil supplementation on cutaneous Leishmania amazonensis infection in mice.

M. Netea, V. Zilberfarb, W. Buurman, 2002, Cytokine.

Effect of psychiatric disorders on outcome of cognitive-behavioural therapy for chronic fatigue syndrome.

G. Bleijenberg, J. Prins, J. V. D. van der Meer, 2005, The British journal of psychiatry : the journal of mental science.

Long-Lasting Transcriptional Changes in Circulating Monocytes of Acute Q Fever Patients

L. Joosten, M. Netea, R. ter Horst, 2019, Open forum infectious diseases.

Cytokine profiles in patients with Q fever fatigue syndrome.

L. Joosten, M. Netea, J. V. D. van der Meer, 2019, The Journal of infection.

Neisseria meningitidis can induce pro-inflammatory cytokine production via pathways independent from CD14 and toll-like receptor 4.

M. Netea, J. V. D. van der Meer, M. van Deuren, 2002, European cytokine network.

Barriers to implementing infection prevention and control guidelines during crises: Experiences of health care professionals

R. Grol, M. Hulscher, J. V. D. van der Meer, 2010, American Journal of Infection Control.

[Immunodeficiency in The Netherlands: clinical and immunological survey, 1970-1983. Interfacultaire werkgroep Immunodeficiëntie].

J. V. D. van der Meer, R. Weening, C. Weemaes, 1994, Nederlands tijdschrift voor geneeskunde.

[Chronic fatigue syndrome].

J. V. D. van der Meer, 1997, Nederlands tijdschrift voor geneeskunde.

The role of clinical guidelines, policies and stewardship.

J. V. D. van der Meer, S. Natsch, 2003, The Journal of hospital infection.

Risk of infections in patients with gout: a population-based cohort study

L. Joosten, P. Souverein, A. Boonen, 2017, Scientific Reports.

Letter to the Editor: The experience of fatigue in the brain

P. Hagoort, I. Toni, F. D. de Lange, 2008, Psychological Medicine.

The Qure study: Q fever fatigue syndrome – response to treatment; a randomized placebo-controlled trial

G. Bleijenberg, H. Knoop, J. V. D. van der Meer, 2013, BMC Infectious Diseases.

Reply to Raoult.

G. Bleijenberg, H. Knoop, J. V. D. van der Meer, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diagnosing chronic fatigue syndrome: comparison of a protocol and computerised questionnaires.

G. Bleijenberg, J. Prins, J. Prins, 2003, The Netherlands journal of medicine.

[Antibiotic policy in Dutch hospitals].

W. Wijnands, J. V. D. van der Meer, R. Janknegt, 1995, Nederlands tijdschrift voor geneeskunde.

Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts.

M. Netea, D. Schwartz, P. Schlag, 2010, Critical care.

[Pertussis: current epidemiology and recommendations of the Health Council with regard to vaccination policy].

J. V. D. van der Meer, H. Visser, J. V. van Wijngaarden, 2000, Nederlands tijdschrift voor geneeskunde.

Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole.

T. Vree, J. V. D. van der Meer, A. J. van der Ven, 1994, British journal of clinical pharmacology.

Resistance to selective decontamination: the jury is still out.

J. V. D. van der Meer, C. Vandenbroucke-Grauls, 2013, The Lancet. Infectious diseases.

Bartonella quintana lipopolysaccharide (LPS): structure and characteristics of a potent TLR4 antagonist for in-vitro and in-vivo applications

L. Joosten, M. Netea, J. V. D. van der Meer, 2016, Scientific Reports.

Letter to the Editor: Chronic fatigue in Gulf War veterans: should it be treated as chronic fatigue syndrome?

G. Bleijenberg, H. Knoop, J. V. D. van der Meer, 2009, Psychological Medicine.

Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood.

M. Bennish, C. Dinarello, G. Keusch, 1992, Journal of leukocyte biology.

In vitro production of IL 1 beta, IL 1 alpha, TNF and IL2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation.

C. Dinarello, J. V. D. van der Meer, J. Cannon, 1989, European journal of immunology.

The Role of Dectin-2 for Host Defense Against Disseminated Candidiasis

L. Joosten, M. Netea, N. Gow, 2016, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

D. Clauw, R. Moss‐Morris, J. V. D. van der Meer, 2015, Annals of Internal Medicine.

Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment

L. Joosten, E. Bronkhorst, H. Knoop, 2017, Journal of Translational Medicine.

Pitfalls in cytokine measurements - Plasma TGF-β1 in chronic fatigue syndrome.

L. Joosten, H. Knoop, M. E. van der Schaaf, 2018, Netherlands Journal of Medicine.

A radioimmunoassay for human interleukin-1 alpha: measurement of IL-1 alpha produced in vitro by human blood mononuclear cells stimulated with endotoxin.

C. Dinarello, J. V. D. van der Meer, J. Cannon, 1988, Lymphokine research.

Guided self-instructions for people with chronic fatigue syndrome: randomised controlled trial

G. Bleijenberg, H. Knoop, J. V. D. van der Meer, 2008, British Journal of Psychiatry.

A salty taste to autoimmunity.

M. Netea, J. V. D. van der Meer, 2013, The New England journal of medicine.

Transient bilateral cortical blindness as a presenting symptom of infective endocarditis.

J. V. D. van der Meer, A. Stalenhoef, J. Timmermans, 1996, The Netherlands journal of medicine.

Long-term effect of cognitive behavioural therapy and doxycycline treatment for patients with Q fever fatigue syndrome: One-year follow-up of the Qure study.

G. Bleijenberg, H. Knoop, J. V. D. van der Meer, 2019, Journal of psychosomatic research.

[Widely divergent clinical phenotype of X-linked agammaglobulinemia in two cousins].

J. V. D. van der Meer, 2004, Nederlandsch tijdschrift voor geneeskunde.

The infectious disease challenges of our time

J. V. D. van der Meer, 2013, Front. Public Health.

Infection with Mycobacterium tuberculosis Beijing genotype strains is associated with polymorphisms in SLC11A1/NRAMP1 in Indonesian patients with tuberculosis.

M. Netea, B. Alisjahbana, T. Ottenhoff, 2009, The Journal of infectious diseases.

Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity

R. Xavier, L. Joosten, C. Wijmenga, 2014, Science.

Growth on Carbohydrates from Carbonaceous Meteorites Alters the Immunogenicity of Environment-Derived Bacterial Pathogens.

M. Netea, P. Rettberg, H. O. D. op den Camp, 2020, Astrobiology.

Inflammasome-independent regulation of IL-1-family cytokines.

L. Joosten, M. Netea, C. Dinarello, 2015, Annual review of immunology.

Dynamic Changes in Pro- and Anti-Inflammatory Cytokine Profiles and Gamma Interferon Receptor Signaling Integrity Correlate with Tuberculosis Disease Activity and Response to Curative Treatment

B. Alisjahbana, T. Ottenhoff, T. de Boer, 2006, Infection and Immunity.

IL-1β Processing in Host Defense: Beyond the Inflammasomes

L. Joosten, M. Netea, B. Kullberg, 2010, PLoS pathogens.

The macrophage mannose receptor induces IL-17 in response to Candida albicans.

L. Joosten, M. Netea, David L. Williams, 2009, Cell host & microbe.

Candida albicans Primes TLR Cytokine Responses through a Dectin-1/Raf-1–Mediated Pathway

Trees Jansen, L. Jacobs, L. Joosten, 2013, The Journal of Immunology.

The anti-CD20 antibody rituximab reduces the Th17 cell response.

L. Joosten, M. Netea, F. D. Di Padova, 2011, Arthritis and rheumatism.

Candida albicans Dampens Host Defense by Downregulating IL-17 Production

S. Smeekens, L. Joosten, M. Netea, 2010, The Journal of Immunology.

Effect of Clarithromycin in Inflammatory Markers of Patients with Ventilator-Associated Pneumonia and Sepsis Caused by Gram-Negative Bacteria: Results from a Randomized Clinical Study

M. Netea, S. Orfanos, A. Kotanidou, 2012, Antimicrobial Agents and Chemotherapy.

Fatigue Is Associated With Altered Monitoring and Preparation of Physical Effort in Patients With Chronic Fatigue Syndrome.

I. Toni, K. Roelofs, F. D. de Lange, 2018, Biological psychiatry. Cognitive neuroscience and neuroimaging.

Pitfalls in cytokine measurements - Plasma TGF-β1 in chronic fatigue syndrome.

L. Joosten, H. Knoop, M. E. van der Schaaf, 2018, The Netherlands journal of medicine.

Development of a sensitive ELISA for the quantification of human tumour necrosis factor-alpha using 4 polyclonal antibodies.

F. Sweep, A. Geurts-Moespot, N. Grebenchtchikov, 2005, European cytokine network.

Adaptation and memory in innate immunity.

L. Joosten, M. Netea, J. V. D. van der Meer, 2016, Seminars in immunology.

Translational Medicine Policy Issues in Infectious Disease

V. ter meulen, J. V. D. van der Meer, R. Fears, 2010, Science Translational Medicine.

Hemofiltration in septic patients is not able to alter the plasma concentration of cytokines therapeutically

J. V. D. van der Meer, M. van Deuren, 2000, Intensive Care Medicine.

Resistance after selective decontamination.

J. Vandenbroucke, J. V. D. van der Meer, C. Vandenbroucke-Grauls, 2012, The Lancet. Infectious diseases.

Observable phenomena that reveal medical students' clinical reasoning ability during expert assessment of their history taking: a qualitative study

J. V. D. van der Meer, C. M. Haring, C. Postma, 2017, BMC Medical Education.

[Emerging pathogens].

J. V. D. van der Meer, A. Overbeke, P. Kager, 1996, Nederlands tijdschrift voor geneeskunde.

Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial.

M. Netea, C. Dinarello, A. Katoulis, 2016, JAMA dermatology.

Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever.

J. V. D. van der Meer, P. Demacker, W. Dolmans, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Candida Th17 response is dependent on mannan- and beta-glucan-induced prostaglandin E2.

S. Smeekens, L. Joosten, M. Netea, 2010, International immunology.

Posttranscriptional down-regulation of tumor necrosis factor-alpha and interleukin-1beta production in acute meningococcal infections.

M. Netea, R. Sauerwein, J. V. D. van der Meer, 1998, The Journal of infectious diseases.

Influence of innate cytokine production capacity on clinical manifestation and severity of pediatric meningococcal disease

J. V. D. van der Meer, M. van Deuren, T. Sprong, 2009, Critical care medicine.

The relations among body consciousness, somatic symptom report, and information processing speed in chronic fatigue syndrome.

G. Bleijenberg, J. V. D. van der Meer, S. P. van der Werf, 2002, Neuropsychiatry, neuropsychology, and behavioral neurology.